These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SYNCHRONOSS TECHNOLOGIES, INC.
|
|
(Name of Registrant as Specified In Its Charter)
|
|
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
|
|
Payment of Filing Fee (Check the appropriate box):
|
|||
|
þ
|
|
No fee required.
|
|
|
o
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
|
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
|
|
(5)
|
Total fee paid:
|
|
o
|
|
Fee paid previously with preliminary materials.
|
|
|
o
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
|
|
|
(1)
|
Amount Previously Paid:
|
|
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
|
|
(3)
|
Filing Party:
|
|
|
|
(4)
|
Date Filed:
|
|
•
|
Election of one member of the Company's Board of Directors to serve until the 2020 annual meeting of stockholders of the Company;
|
|
•
|
Ratification of appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31,
2017
;
|
|
•
|
Advisory vote on executive compensation;
|
|
•
|
Advisory vote on the frequency of future advisory votes on executive compensation; and
|
|
•
|
Transaction of other business that may properly come before the meeting.
|
|
|
|
||
|
Proxy Summary
|
|
|
For More Information
|
Board Recommendation
|
||
|
Proposal 1: Election of one director
Thomas J. Hopkins
|
Page
56
|
|
|
For Nominee
|
|
Proposal 2:
Ratification of appointment of Ernst & Young LLP as independent registered public accountants
|
Page
61
|
|
|
For
|
|
Proposal 3:
Advisory vote on executive compensation
|
Page
63
|
|
|
For
|
|
Proposal 4:
Advisory vote on frequency of future advisory votes on executive compensation
|
Page
64
|
|
|
For every "1 Year"
|
|
|
|
|
|
|
|
|
Internet
|
|
Phone
|
|
Mail
|
|
In Person
|
|
You may vote by proxy via the Internet at
www.proxyvote.com
by following the instructions provided in the Notice or, if you requested printed copies of the proxy materials by mail, by following the instructions provided in the proxy card.
|
|
You may vote by proxy by telephone by following the instructions provided in the Notice or, if you requested printed copies of the proxy materials by mail, by calling the toll free number found on the proxy card.
|
|
If you requested printed copies of the proxy materials by mail, you will receive a proxy card and you may vote by proxy by filling out, signing and dating the proxy card, and returning it in the envelope provided.
|
|
Attend the Annual Meeting at our Headquarters located at 200 Crossing Blvd., 8th Floor, Bridgewater, NJ 08807.
|
|
See "Proposals" starting on page
56
for more information.
|
|
Matter
|
Board vote recommendation
|
|
Management proposals:
|
|
|
Election of Director
|
For the director nominee
|
|
Ratification of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2017
|
For
|
|
Advisory vote on Executive Compensation
|
For
|
|
Advisory vote on Frequency of Future Advisory Votes on Executive Compensation
|
For every "1 year"
|
|
Name
|
Age
|
Director
Since
|
Occupation
|
Independent
|
Committee memberships
|
|||
|
AC
|
CC
|
NCGC
|
BDC
|
|||||
|
Thomas J. Hopkins
|
60
|
2004
|
Managing Director, Colchester Capital, LLC
|
Yes
|
M
|
M
|
|
C
|
|
AC
|
Audit Committee
|
BDC
|
Business Development Committee
|
|
CC
|
Compensation Committee
|
C
|
Chair
|
|
NCGC
|
Nominating/Corporate Governance Committee
|
M
|
Member
|
|
•
|
Adjustments to Base Salary:
In reviewing the base salaries of Messrs. Waldis and Garcia in early 2016, our Compensation Committee approved salary increases to each of them of approximately 3% (representing the median base salary increase). In addition, each of Ms. Rosenberger's and Mr. Prague's base salary was below the competitive range of similarly situated roles at our peer group companies and based on this and other publicly-available information, they received base salary increases of
9%
and
6%
, respectively. As a result of his promotion to Executive Vice President, Sales in January 2016, Mr. Putnam received a base salary increase of
36%
based on our Compensation Committee's review of the base salaries of similarly situated employees at our peer group companies and other publicly-available information.
|
|
•
|
Performance-based Cash Bonus:
Our
2016
Adjusted Non-GAAP revenue and Adjusted Non-GAAP EBITDA were above the target set by our Board for
2016
but below the maximum level. As a result, our NEOs (other than Mr. Putnam) received approximately
113%
of their target cash incentive bonus amounts with respect to the corporate goal portion. Messrs. Waldis, Garcia and Prague and Ms. Rosenberger received
100%
of their target bonus amounts for the individual component portion. Due to his role as Executive Vice President, Sales, our Compensation Committee determined that Mr. Putnam' cash incentive bonus would be based 100% on certain individual objectives, all of which he met and therefore he received 100% of his target cash incentive bonus.
|
|
•
|
Performance-based Equity: A
s part of the transition to a three-year long term incentive plan in
2015
, each NEO received a one-time transition equity award to address the vesting opportunity 'gap' between the old and new plans. Vesting of this transition equity award was contingent upon the achievement of non-GAAP revenue, non-GAAP EBITDA and non-GAAP Cloud revenue goals both in 2015 and 2016. With respect to the portion of the transition equity awards earned with respect to 2016 performance, our 2016 non-GAAP revenue and non-GAAP EBITDA were above the target set by our Board for 2016 but below the maximum performance level. Our 2016 non-GAAP Cloud revenue was above the minimum threshhold level but below target. As a result, our NEOs were issued an aggregate of
35,727
restricted shares of our Common Stock, or
101%
of the target number of performance-based restricted shares under the
2015
-
2016
performance-based restricted stock awards.
|
|
•
|
Time-Based Equity:
Our NEOs were granted (i) an aggregate of
122,463
time-based restricted shares of our Common Stock and (ii) stock options to purchase an aggregate of
299,184
shares of our Common Stock.
|
|
QUESTIONS & ANSWERS ABOUT THIS PROXY MATERIAL & VOTING MATTERS
|
|
Q:
|
Why am I receiving these proxy materials?
|
|
A:
|
Our Board is providing these proxy materials to you in connection with the solicitation of proxies for use at the Annual Meeting to be held on
Tuesday, May 16, 2017
at 10:00 a.m. local time, and at any adjournment or postponement thereof, for the purpose of considering and acting upon the matters set forth herein. The Notice of Annual Meeting, this Proxy Statement and accompanying form of proxy card are being made available to you on or about
April 6, 2017
. This Proxy Statement includes information that we are required to provide to you under rules promulgated by the U.S. Securities and Exchange Commission (the "
SEC
") and that is designed to assist you in voting your shares.
|
|
•
|
This Proxy Statement for the Annual Meeting;
|
|
•
|
Our
2016
Annual Report to Stockholders, which consists of our Annual Report on Form 10-K for the year ended
December 31, 2016
; and
|
|
•
|
The proxy card or a voting instruction form for the Annual Meeting, if you have requested that the proxy materials be mailed to you.
|
|
Q:
|
How can I get electronic access to the proxy materials?
|
|
A:
|
The Company's proxy materials are available at
http://materials.proxyvote.com/87157B
and at
www.synchronoss.com
. Our website address is included for reference only. The information contained on our website is not incorporated by reference into this Proxy Statement.
|
|
Q:
|
Who can vote at the Annual Meeting?
|
|
A:
|
Only stockholders of record at the close of business on
March 27, 2017
will be entitled to vote at the Annual Meeting. On this record date, there were
46,372,470
shares of the Company's common stock ("
Common Stock
") outstanding. All of these outstanding shares of Common Stock are entitled to vote at the Annual Meeting (one vote per share of Common Stock) in connection with the matters set forth in this Proxy Statement. A list of stockholders entitled to vote at the Annual Meeting will be available for inspection at Synchronoss' principal executive offices at 200 Crossing Boulevard, Bridgewater, New Jersey for the ten-day period prior to the Annual Meeting.
|
|
Q:
|
How do I vote at the Annual Meeting?
|
|
A:
|
Stockholder of Record: Shares Registered in Your Name
|
|
•
|
By Internet
— You may vote by proxy via the Internet at
www.proxyvote.com
by following the instructions provided in the Notice or, if you requested printed copies of the proxy materials by mail, by following the instructions provided in the proxy card.
|
|
•
|
By Telephone
— You may vote by proxy by telephone by following the instructions provided in the Notice or, if you requested printed copies of the proxy materials by mail, by calling the toll free number found on the proxy card.
|
|
•
|
By Mail
— If you request printed copies of the proxy materials by mail, you will receive a proxy card and you may vote by proxy by filling out the proxy card and returning it in the envelope provided.
|
|
Q.
|
How many votes do I have?
|
|
A.
|
On each matter to be voted upon, you have one vote for each share of Common Stock you owned as of
March 27, 2017
.
|
|
Q.
|
What if I do not make specific voting selections?
|
|
A.
|
Stockholder of Record
— If you are a stockholder of record and you:
|
|
•
|
Indicate when voting on the Internet or by telephone that you wish to vote as recommended by our Board, or
|
|
•
|
Sign and return a proxy card without giving specific voting instructions,
|
|
Q.
|
Can I change my vote after submitting my proxy?
|
|
A.
|
Yes. You can revoke your proxy at any time before the final vote at the Annual Meeting. If you are the record holder of your shares, you may revoke your proxy in any one of three ways:
|
|
•
|
You may change your vote using the Internet or telephone methods described above prior to 11:59 p.m., Eastern Time on
May 15, 2017
, in which case only your latest Internet or telephone proxy submitted prior to the Annual Meeting will be counted.
|
|
•
|
You may submit another properly completed timely proxy card with a later date.
|
|
•
|
You may send a written notice that you are revoking your proxy to the Company's Secretary at 200 Crossing Boulevard, Bridgewater, New Jersey 08807.
|
|
•
|
You may attend the Annual Meeting and vote in person. Simply attending the meeting will not, by itself, revoke your previously delivered proxy.
|
|
Q.
|
Who is paying for this proxy solicitation?
|
|
A.
|
The Company will pay for the entire cost of soliciting proxies for the Annual Meeting. In addition to the proxy materials, our directors and employees may also solicit proxies in person, by telephone or by other means of communication. Directors and employees will not be paid any additional compensation for soliciting proxies. The Company may reimburse brokerage firms, banks and other agents for the cost of forwarding proxy materials.
|
|
Q:
|
Why did I receive a notice regarding the availability of proxy materials on the Internet instead of a full set of proxy materials?
|
|
A:
|
In accordance with the rules promulgated by the SEC, we have elected to furnish our proxy materials, including this Proxy
|
|
Q:
|
What does it mean if multiple members of my household are stockholders but we only received one Notice or full set of proxy materials in the mail?
|
|
A:
|
We have adopted a procedure called "householding," which the SEC has approved. Under this procedure, we deliver a single copy of the Notice and, if applicable, the proxy materials to multiple stockholders who share the same address unless we received contrary instructions from one or more of the stockholders at that address. This procedure reduces our printing costs, mailing costs, and fees. Stockholders who participate in householding will continue to be able to access and receive separate proxy cards. Upon written request, we will deliver promptly a separate copy of the Notice and, if applicable, the proxy materials to any stockholder at a shared address to which we delivered a single copy of any of these documents. To receive a separate copy of the Notice and, if applicable, the proxy materials, stockholders should send their requests to our principal executive offices, Attention: Secretary. Stockholders who hold shares in street name (as described below) may contact their brokerage firm, bank, broker-dealer, or other similar organization to request information about householding.
|
|
A.
|
Each share of Common Stock is entitled to one vote. Votes will be counted by the inspector of election appointed for the Annual Meeting. Prior to the Annual Meeting, the inspector will sign an oath to perform his or her duties in an impartial manner and according to the best of his or her ability. The inspector will determine the number of shares of Common Stock represented at the Annual Meeting and the validity of proxies and ballots, count all votes and ballots and perform certain other duties. The determination of the inspector of elections as to the validity of proxies will be final and binding.
|
|
Q.
|
What vote is required to approve each proposal?
|
|
•
|
Our directors are elected by a plurality of the votes cast at an annual meeting of stockholders, meaning the nominee(s) receiving the most "For" votes (among votes properly cast in person or by proxy) will be elected. An instruction to "Withhold" authority to vote for a nominee will result in the nominee receiving fewer votes, but will not count as a vote against the nominee. If you do not instruct your broker how to vote with respect to this proposal, your broker may not vote with respect to this proposal. Abstentions and "broker non-votes" (i.e., shares held by a broker or nominee that are represented at the Annual Meeting, but with respect to which such broker or nominee is not instructed to vote on a particular proposal and does not have discretionary voting power) will have no effect on the election of a nominee.
|
|
•
|
Ratification of the appointment by our Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for our fiscal year ending December 31,
2017
, requires a "For" vote from the majority of all of the outstanding shares that are present in person or represented by proxy and cast affirmatively or negatively at the Annual Meeting. Abstentions and broker non-votes will not be counted "For" or "Against" this proposal and will have no effect on this proposal. Because this proposal is a routine matter, a broker or other nominee may
|
|
•
|
The advisory approval of the compensation of the Company's NEOs as described in this Proxy Statement requires a "For" vote from the majority of all of the outstanding shares that are present in person or represented by proxy and cast affirmatively or negatively at the Annual Meeting. Abstentions and broker non-votes will not be counted "For" or "Against" this proposal and will have no effect on this proposal. Even though your vote is advisory and therefore will not be binding on the Company, our Compensation Committee will review the voting results and take them into consideration when making future executive compensation decisions.
|
|
•
|
The advisory vote on the frequency of future advisory votes on the compensation of the Company's NEOs as described in this Proxy Statement requires a "For" vote for one of the three options presented: every "1 Year," "2 Years" or "3 Years". The option receiving the plurality of votes from the outstanding shares that are present in person or represented by proxy and cast affirmatively or negatively at the Annual Meeting will be the option deemed approved by our stockholders. Abstentions and broker non-votes will not be counted "For" or "Against" this proposal and will have no effect on this proposal. Even though your vote is advisory and therefore will not be binding on the Company, our Compensation Committee will review the voting results and take them into consideration when making future determinations about how frequently to ask the Company's stockholders to consider an advisory proposal on executive compensation.
|
|
A.
|
Proxies, ballots and voting tabulations are handled on a confidential basis to protect your voting privacy. This information will not be disclosed, except as required by law.
|
|
A.
|
A quorum of stockholders is necessary to hold a valid stockholders meeting. A quorum will be present if a majority of the voting power of all of the Company's outstanding shares is represented by stockholders present at the Annual Meeting in person or by proxy. On the record date, there were
46,372,470
shares of Common Stock outstanding and entitled to vote. Thus,
23,186,236
shares must be represented by stockholders present at the Annual Meeting in person or by proxy to have a quorum. Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, bank or other agent) or vote in person at the Annual Meeting. Abstentions and broker non-votes will be counted towards the quorum requirement.
|
|
Q.
|
How can I find out the results of the voting at the Annual Meeting?
|
|
A.
|
Preliminary voting results will be announced at the Annual Meeting. Final voting results will be set forth in a Current Report on Form 8-K to be filed by the Company with the SEC no later than four business days after the Annual Meeting.
|
|
Corporate Governance at Synchronoss
|
|
CORPORATE GOVERNANCE GUIDELINES
|
|
BOARD LEADERSHIP STRUCTURE
|
|
INDEPENDENCE OF OUR BOARD OF DIRECTORS
|
|
BOARD OF DIRECTORS OVERSIGHT OF RISK MANAGEMENT
|
|
BOARD SELF-EVALUATION
|
|
STOCKHOLDER COMMUNICATIONS WITH OUR BOARD OF DIRECTORS
|
|
BOARD OF DIRECTORS AND COMMITTEE DUTIES
|
|
•
|
overseeing the conduct, assessment and other operational risks to evaluate whether our business is being properly managed;
|
|
•
|
reviewing and approving our strategic, financial and operating plans and other significant actions;
|
|
•
|
evaluating the performance of and reviewing and determining the compensation of our CEO and other executive officers;
|
|
•
|
planning for succession for our CEO and monitoring management's succession planning for other executive officers; and
|
|
•
|
overseeing the processes for maintaining the integrity of our financial statements, public disclosures, and compliance with laws and ethics.
|
|
BOARD STRUCTURE AND COMMITTEES
|
|
Name*
|
Audit Committee
|
Compensation Committee
|
Nominating/Corporate Governance Committee
|
Business
Development Committee
|
|
Stephen G. Waldis
|
|
|
|
M
|
|
William J. Cadogan
|
M
|
C
|
M
|
M
|
|
Thomas J. Hopkins
|
M
|
M
|
|
C
|
|
James M. McCormick
|
|
M
|
C
|
|
|
Donnie M. Moore
|
C
|
|
M
|
|
|
Total meetings in year 2016
|
9
|
5
|
1
|
5
|
|
*
|
Mr. Hovsepian is excluded from this table as he joined the Board in January 2017. He does not presently sit on any Board committees. Mr. Hoffman is also excluded from this table as he did not run for re-election at the 2016 Annual Meeting of Stockholders and his service on our Board terminated effective May 17, 2016.
|
|
AUDIT COMMITTEE
|
|
•
|
reviews our annual audited and quarterly financial statements and SEC reporting;
|
|
•
|
reviews the Company's assessment of risk pertaining to our reporting and disclosure controls and monitors our internal controls and audit functions, the results and scope of the annual audit and other services provided by our independent registered public accounting firm and our compliance with legal matters that have a significant impact on our financial statements;
|
|
•
|
establishes procedures for the receipt and treatment of complaints regarding internal accounting controls or auditing matters and the confidential, anonymous submission by our employees of concerns regarding questionable accounting or auditing matters;
|
|
•
|
appoints, compensates, reviews procedures to ensure the independence of and oversees the work of, our independent registered public accounting firm, including approving services and fee arrangements;
|
|
•
|
reviews with senior members of our management our policies and practices regarding risk assessment and risk management;
|
|
•
|
approves all related party transactions;
|
|
•
|
reviews periodically the adequacy and effectiveness of our internal and disclosure controls, including our policies regarding compliance with legal, regulatory, code of conduct, ethical and internal auditing standards;
|
|
•
|
reviews earnings press releases prior to issuance; and
|
|
•
|
reviews findings and recommendations of our independent registered public accounting firm and management's response to their recommendations.
|
|
COMPENSATION COMMITTEE
|
|
•
|
review and approve our compensation strategy and philosophy;
|
|
•
|
review and approve our annual corporate goals and objectives related to executive compensation and evaluate performance in light of these goals;
|
|
•
|
review and approve policies and all forms of compensation and other benefits to be provided to our employees (including our NEOs), including among other things the annual base salaries, bonus, stock options, restricted stock grants and other incentive compensation arrangements;
|
|
•
|
evaluate the CEO's performance and determine his salary and incentive compensation;
|
|
•
|
in consultation with the CEO, determine the salaries and incentive compensation of our other executive officers;
|
|
•
|
make recommendations from time to time to our Board regarding non-employee director compensation matters;
|
|
•
|
recommend, for approval by the Board, the adoption or amendment of our equity and cash incentive plans;
|
|
•
|
administer our stock purchase plan and equity incentive plans;
|
|
•
|
oversee the administration of our other material employee benefit plans, including our 401(k) plan; and
|
|
•
|
review and approve other aspects of our compensation policies and matters as they arise from time to time.
|
|
COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
|
|
NOMINATING/CORPORATE GOVERNANCE COMMITTEE
|
|
•
|
reviews and reports to our Board on a periodic basis with regard to matters of corporate governance;
|
|
•
|
recommends qualified candidates to our Board for election as our directors, including the directors our Board proposes for election by the stockholders at the Annual Meeting and directors nominated by our stockholders;
|
|
•
|
reviews, assesses and makes recommendations on the effectiveness of our corporate governance policies and on matters relating to the practices of directors and the functions and duties of the various Board committees;
|
|
•
|
develops and implements our Board's biennial self-assessment process and works with our Board to implement improvements in their effectiveness;
|
|
•
|
reviews succession plans periodically with our CEO relating to positions held by elected corporate officers;
|
|
•
|
reviews and makes recommendations to our Board regarding the size and composition of our Board and the appropriate qualities and skills required of our directors in the context of the then current make-up of our Board and our business; and
|
|
•
|
establishes and periodically reviews stock ownership guidelines for our executive officers and directors.
|
|
BUSINESS DEVELOPMENT COMMITTEE
|
|
DIRECTOR COMPENSATION
|
|
Compensable Position / Event
|
Compensation
|
|
Initial Equity Grant
|
Non-qualified stock option to purchase 30,000 shares
(1)
|
|
Annual Cash Retainer
|
$50,000
|
|
Annual Equity Grant
|
Equity awards with an aggregate grant date fair value of $200,000 60% in restricted shares
(1)
40% in the form of a non-qualified stock option
(1)
|
|
Committee Chairperson Retainer
|
$20,000 (Audit)
$15,000 (Compensation)
$10,000 (Nominating/Corporate Governance)
$10,000 (Business Development)
|
|
Committee Member Retainer
|
$10,000 (Audit)
$7,500 (Compensation)
$5,000 (Nominating/Corporate Governance)
$5,000 (Business Development)
|
|
Name
|
|
Fees Earned or
Paid in Cash
($)
|
Stock Awards
($)(1)
|
Option
Awards
($)(2)
|
Total
($)
|
|
William J. Cadogan
|
|
85,000
|
119,997
|
78,197
|
283,194
|
|
Charles E. Hoffman
|
(3)
|
33,750
|
119,997
|
78,197
|
231,944
|
|
Thomas Hopkins
|
|
77,500
|
119,997
|
78,197
|
275,694
|
|
James McCormick
|
|
50,000
|
119,997
|
78,197
|
248,194
|
|
Donnie M. Moore
|
|
75,000
|
119,997
|
78,197
|
273,194
|
|
(1)
|
The amounts in this column reflect the aggregate grant date fair value of the stock awards computed in accordance with FASB ASC Topic No. 718. See Footnote 13 to the financial statements included in our Annual Report on Form 10-K for the year ended
December 31, 2016
for a discussion of our assumptions in estimating the fair value of our stock awards. As of
December 31, 2016
, each of Messrs. Cadogan, Hopkins, McCormick and Moore held
6,916
restricted shares of our Common Stock. Mr. Hoffman resigned from our Board effective May 17, 2016 and did not hold any restricted shares of Common Stock as of
December 31, 2016
.
|
|
(2)
|
The amounts in this column reflect the aggregate grant date fair value of the stock options computed in accordance with FASB ASC Topic No. 718. See Footnote 13 to the financial statements included in our Annual Report on Form 10-K for the year ended
December 31, 2016
for a discussion of our assumptions in estimating the fair value of our stock option awards. As of
December 31, 2016
, each of Messrs. Hopkins and McCormick held unexercised options to purchase
44,014
shares of our Common Stock having a weighted average exercise price of
$30.18
per share, of which
30,000
shares were vested; Mr. Cadogan held unexercised options to purchase
51,514
shares of our Common Stock, having a weighted average exercise price of
$28.10
per share, of which
37,500
shares were vested; and Mr. Moore held options to purchase
64,514
shares of our Common Stock, having a weighted average exercise price of
$27.74
per share, of which
50,500
shares were vested. As of
December 31, 2016
, Mr. Hoffman did not hold any outstanding unexercised stock options. The options granted to our non-employee directors in
2016
were granted at an exercise price of
$33.50
per share.
|
|
(3)
|
Mr. Hoffman did not run for re-election at the 2016 Annual Meeting of Stockholders and his service on our Board terminated effective May 17, 2016.
|
|
DIRECTOR STOCK OWNERSHIP GUIDELINES
|
|
LIMITATION OF LIABILITY AND INDEMNIFICATION
|
|
•
|
for any breach of a director's duty in respect of unlawful (i) payments of dividends or (ii) stock repurchases or redemptions as provided in Section 174 of the Delaware General Corporation Law and the breach of a director's duty of loyalty to us or our stockholders;
|
|
•
|
for any transaction from which the director derives any improper personal benefit; and
|
|
•
|
for acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law.
|
|
RISK MANAGEMENT CONSIDERATIONS
|
|
|
Financial
Performance
Measures
|
The ranges set for financial performance measures are designed to reward success without encouraging excessive risk taking. Pursuant to our three-year equity plan, the number of performance-based restricted shares to be issued is based on our financial performance over a three-year period. There are maximum payouts under our cash incentive plan and the performance-based restricted shares, which help mitigate risk.
|
|
|
Equity Vesting Periods
|
Time-based restricted shares typically vest over three years, while stock options typically vest over four years. The performance-based restricted shares are earned and vest upon determination of the achievement of our three-year business plan. The vesting of the equity awards is designed to reward continued service with us, increases in our stock price and achievement of corporate goals designed to enhance stockholder value.
|
|
|
Equity Retention Guidelines
|
NEOs are required to acquire within five years of becoming an executive officer, and hold while they are executive officers, shares (vested and unvested) having a value of at least three times, or five times in the case of our CEO, their respective base salaries.
|
|
|
No Hedging
|
NEOs are not permitted to enter into any transaction designed to hedge, or having the effect of hedging, the economic risk of owning our securities.
|
|
|
Financial Restatement, Recoupment and Related Policies
|
As part of our Ethics and Business Conduct Policy, we will investigate all reported instances of questionable or unethical behavior of a director, NEO or other employee and, where improper behavior or failure to act is found to have occurred, will take appropriate action up to and including termination. If an investigation uncovers that an individual has committed fraud or other improper acts that causes our financial statements to be restated or otherwise affected, we will take immediate and appropriate disciplinary action with respect to that individual up to and including termination. We also intend to pursue whatever legal remedies are available to prosecute that individual to the fullest extent of the law and seek to recoup or recover any amounts he or she inappropriately received as a result of his or her improper actions, including but not limited to any annual or long term incentives that he or she received to the extent the individual would not have received that amount had the improper action not been taken.
|
|
Synchronoss Executive Leadership Team
and Executive Officers
|
||||
|
Name
|
Age
|
Positions (as of December 31, 2016)
|
|
Individuals Serving as Executive Officers as of December 31, 2016:
|
||
|
Stephen G. Waldis
(1)
|
49
|
Founder, Chief Executive Officer and Chairman of the Board
|
|
Karen L. Rosenberger
(2)
|
51
|
Executive Vice President and Chief Financial Officer
|
|
Patrick J. Doran
|
44
|
Executive Vice President and Chief Technology Officer
|
|
Robert E. Garcia
|
48
|
President and Chief Operating Officer
|
|
Ronald J. Prague
|
53
|
EVP, Chief Legal Officer, General Counsel and Secretary
|
|
Christopher S. Putnam
|
48
|
Executive Vice President, Sales
|
|
David Schuette
|
51
|
Executive Vice President and President, Enterprise
|
|
Name
|
Age
|
Current Positions
|
|
Current Executive Officers:
|
||
|
Stephen G. Waldis
(1)
|
49
|
Executive Chairman and Founder; Former Chief Executive Officer
|
|
Ronald W. Hovsepian
(1)
|
56
|
Chief Executive Officer and Director
|
|
John W. Frederick
(2)
|
53
|
Chief Financial Officer
|
|
Robert E. Garcia
|
48
|
President and Chief Operating Officer
|
|
John DeFeo
|
54
|
EVP, General Manager, Customer Success and Technology Operations
|
|
Ronald J. Prague
|
53
|
EVP, Chief Legal Officer, General Counsel & Secretary
|
|
(1)
|
Mr. Hovsepian was appointed as a Director and our Chief Executive Officer on January 19, 2017 in connection with the closing of our acquisition of Intralinks, replacing Mr. Waldis who was appointed Executive Chairman as of that same date.
|
|
(2)
|
Mr. Frederick was appointed as our Chief Financial Officer on February 27, 2017, at which time Ms. Rosenberger resigned as Chief Financial Officer. Ms. Rosenberger remained employed with us through April 1, 2017.
|
|
Name
|
Age
|
Positions
|
|
Current Key Employees:
|
||
|
Patrick J. Doran
|
44
|
Chief Technology Officer, EVP, General Manager, Research & Development, Center of Excellence
|
|
Michael Feinberg
|
54
|
EVP, General Manager, Research & Development, Communications & Media
|
|
Carlos Montero-Luque
|
54
|
EVP, General Manager, Research and Development, Enterprise
|
|
Leif O'Leary
|
45
|
EVP, General Manager, Go-to-Market, Strategic Financials
|
|
David Schuette
|
51
|
EVP, General Manager, Go-to-Market, Enterprise
|
|
Clayton A. Thomas, Jr.
|
54
|
EVP, General Manager, Go-to-Market, Communications & Media
|
|
Christopher S. Putnam
|
48
|
EVP, Sales
|
|
Named Executive Officer
|
|
Title as of December 31, 2016
|
|
|
Stephen G. Waldis
|
(1)
|
|
Founder, Chief Executive Officer and Chairman of the Board
|
|
Karen L. Rosenberger
|
(2)
|
|
Executive Vice President, Chief Financial Officer
|
|
Robert E. Garcia
|
|
|
President and Chief Operating Officer
|
|
Christopher S. Putnam
|
|
|
Executive Vice President, Sales
|
|
Ronald J. Prague
|
|
|
EVP, Chief Legal Officer, General Counsel and Secretary
|
|
(1)
|
Mr. Waldis resigned as our Chief Executive Officer effective January 19, 2017 and was appointed Executive Chairman on such date.
|
|
(2)
|
Ms. Rosenberger resigned as Executive Vice President and Chief Financial Officer effective February 27, 2017. Ms. Rosenberger remained employed with us through April 1, 2017.
|
|
Pay for
Performance
|
Provide a strong relationship of pay to performance through:
• Performance-based cash bonus tied primarily to achievement of corporate short-term financial goals and individual performance.
• Equity awards that deliver value based on the performance of our Common Stock and, in the case of performance-based stock awards, the achievement of pre-determined, objective financial and business goals.
|
|
Emphasis on
Variable Compensation |
• Total compensation is heavily weighted toward incentive compensation (i.e., annual cash bonuses and long-term equity incentives).
• Annual performance-based cash bonuses focus our NEOs on key short-term financial goals.
• Stock options and time-based and performance-based restricted shares incentivize our NEOs to focus on sustainable, long-term stockholder value creation. The value realized by our NEOs depends substantially on our long-term performance, achievement of our strategic goals and the value of our Common Stock, which we believe aligns our NEOs' interests with the long-term interests of our stockholders.
|
|
Fixed
Compensation
Component
|
• Provide base salary based on our Compensation Committee's general understanding of current competitive compensation practices, corporate achievement, the role in which a NEO serves and the NEO's responsibilities, length of tenure, internal pay equity and individual performance.
|
|
At-Risk Compensation
|
A majority of the compensation of our CEO and our other NEOs is "at-risk" and tied to Company performance over the short- and/or long-term.
|
|
Incentive Award Metrics
|
Establish and approve difficult to achieve objective incentive award metrics tied to key Company performance indicators.
|
|
Three-Year Performance Equity Plan
|
The number of performance-based restricted shares earned is based on our financial performance over a three-year period, aligning our NEOs' interests with the long-term interests of our stockholders.
|
|
Time-Based Equity Vesting
|
Equity awards subject to time-based vesting vest incrementally over three or four years to promote retention.
|
|
Stock Ownership Guidelines
|
Maintain stock ownership guidelines to support the alignment of interests between our NEOs and stockholders.
|
|
No Hedging
|
Prohibition of hedging exposure of, or interest in, our Common Stock.
|
|
•
|
45%
based on the Company's non-GAAP revenue* for
2016
;
|
|
•
|
45%
based on the Company's non-GAAP EBITDA* for
2016
; and
|
|
•
|
10%
based on the NEO's individual performance.
|
|
•
|
60% are earned based on three-year average annual non-GAAP revenue* growth of our Company from
2016
to
2018
;
|
|
•
|
30% are earned based on three-year average annual non-GAAP EBITDA* from
2016
to
2018
; and
|
|
•
|
10% are earned based on three-year annual revenue growth in our Enterprise business from
2016
to
2018
.
|
|
2016 Say on Pay Vote
|
|
Compensation Consultant
|
|
Peer Group
|
|
Blackbaud, Inc.
|
Interactive Intelligence Group, Inc.
|
NeuStar, Inc.
|
|
Bottomline Technologies, Inc.
|
J2 Global, Inc.
|
Pegasystems, Inc.
|
|
CommVault Systems, Inc.
|
LogMein, Inc.
|
Progress Software Corp.
|
|
Cornerstone OnDemand Inc.
|
Medidata Solutions, Inc.
|
SolarWinds Inc.
|
|
Fleetmatics Group PLC
|
Microstrategy, Inc.
|
The Ultimate Software Group
|
|
Guidewire Software Inc.
|
|
|
|
Base Salary
|
Objective:
|
||
|
|
Our Compensation Committee sets base salaries with the intent to attract and retain executives, reward satisfactory performance and provide a minimum, fixed level of cash compensation to compensate NEOs for their day-to-day responsibilities.
|
||
|
|
Key Features:
|
||
|
|
•
|
|
Executive base salaries are initially determined as a result of negotiation between the executive and our management in consultation with, and subject to the approval of, our Compensation Committee.
|
|
|
•
|
|
Our Compensation Committee reviews base salaries annually and has discretion to provide increases based on our Compensation Committee's understanding of current competitive pay practices, promotions, our CEO's recommendation (except in the case of his own salary), changes in responsibilities and performance, annual budget for increases, our overall financial and operational results, the general economy, length of tenure and internal pay equity and other factors our Compensation Committee deems appropriate.
|
|
|
Process:
|
||
|
|
•
|
|
At the end of each calendar year, our CEO recommends base salaries for executives other than himself for the following calendar year.
|
|
|
•
|
|
Our Compensation Committee reviews proposed base salary changes with input from its compensation consultant.
|
|
|
•
|
|
Our Compensation Committee approves base salaries for our NEOs.
|
|
|
•
|
|
Our Compensation Committee reports base salary determinations to our full Board.
|
|
Annual Cash
|
Objective:
|
|
|
Incentive Bonus
|
Annual cash incentive bonuses are awarded under a performance-based compensation program and are designed to align the interests of our NEOs and stockholders by providing compensation based on the achievement of pre-determined corporate and/or business goals and individual performance.
|
|
|
|
Key Features:
|
|
|
|
•
|
Each year, the target bonus for each NEO is set by our Compensation Committee based on the provisions of each NEO's employment agreement, our CEO's recommendation (except in the case of his own target), internal pay equity, our Compensation Committee's general understanding of current competitive pay practices and other factors it deems appropriate.
|
|
|
•
|
At least 90% of the incentive compensation for our NEOs other than Mr. Putnam is based on achievement of certain objective corporate financial goals established and approved by our Compensation Committee at the start of the year. Because Mr. Putnam is responsible for our worldwide sales, our Compensation Committee determined that his cash incentive bonus would be determined based entirely on achievement of individual objectives.
|
|
|
•
|
If we achieve results that are below certain threshold levels, these NEOs receive no cash incentive bonus, while results that are above certain threshold levels result in cash incentive bonuses above target levels.
|
|
|
Process:
|
|
|
|
•
|
Our Compensation Committee participates in our Board's review of our annual operating plan at the beginning of the year.
|
|
|
•
|
Our CEO recommends bonus targets as a percentage of base salary for each NEO other than himself.
|
|
|
•
|
Our management recommends financial and other performance measures, weightings and ranges.
|
|
|
•
|
Our Compensation Committee reviews proposed bonus targets, performance measures and ranges provided by management and, with input from its compensation consultant, approves bonus targets, performance measures and ranges that it believes establish appropriately challenging goals.
|
|
|
•
|
After the end of the fiscal year, our management presents the Company's financial results to our Board.
|
|
|
•
|
Our CEO recommends the individual component award for each of our NEOs other than himself.
|
|
|
•
|
Our Compensation Committee reviews the results and determines whether to make any adjustments to the recommendations and then approves each NEO's bonus award.
|
|
|
•
|
Our Compensation Committee reports bonus award determinations to our full Board.
|
|
Equity Awards
|
Objectives:
|
|
|
|
Our Compensation Committee structures equity awards to align our NEOs' interests with those of our stockholders, support retention and motivate NEOs to achieve our financial, strategic and operational goals. Equity awards include stock options and time-based and performance-based restricted shares.
|
|
|
|
Key Features:
|
|
|
|
•
|
Our Compensation Committee grants stock options and time-based and performance-based restricted shares to our NEOs with a grant date fair value determined based on our Compensation Committee's general understanding of current competitive pay practices, our CEO's recommendation (except in the case of his own awards), recommendations from our compensation consultant, internal pay equity, evaluation of each NEO's performance, and other factors our Compensation Committee deems appropriate.
|
|
|
•
|
Long-term incentive awards are allocated, based on grant date fair value, as follows (with vesting terms that generally extend up to four years):
|
|
|
|
o One-third stock options
|
|
|
|
o One-third time-based restricted shares
|
|
|
|
o One-third performance-based restricted shares
|
|
|
|
Our Compensation Committee believes this mix provides NEOs with a balanced retention and performance opportunity and serves to closely align our NEOs' long-term objectives with those of our stockholders.
|
|
|
•
|
Each performance-based restricted share award has a target number of shares to be earned following completion of a three-year performance period based on the achievement of certain pre-established Company performance criteria. These performance-based restricted shares will be earned and vest upon the completion of the three-year fiscal period if the relevant performance criteria are achieved.
|
|
|
Process:
|
|
|
|
•
|
In the first fiscal quarter, our CEO recommends grant date fair values of awards for executives other than himself.
|
|
|
•
|
Our Compensation Committee reviews proposed awards with input from its compensation consultant.
|
|
|
•
|
Our Compensation Committee approves the number of time-based shares underlying stock options and the target number of time-based and performance-based restricted shares granted to our NEOs.
|
|
|
•
|
Our Compensation Committee reports equity award determinations to our full Board.
|
|
Severance and Change in Control Benefits
|
Objectives:
|
|
|
Severance and change in control benefits are included in each NEO's employment agreement in order to promote stability and continuity of our senior management team in the event of a potential change in control and/or any involuntary termination. Our Compensation Committee believes these provisions help to align our NEOs' interests appropriately with those of our stockholders in these scenarios.
|
||
|
|
Key Features:
|
|
|
|
•
|
Events triggering payment require a termination of our NEOs' employment by our Company without cause or by the executive for good reason. Executives are entitled to enhanced benefits if the qualifying termination occurs during a specified period following a change in control (i.e., double-trigger).
|
|
|
•
|
Change in Control benefits do not include excise tax gross-ups.
|
|
|
•
|
Our Compensation Committee has determined these termination-related benefits are appropriate to preserve productivity and encourage retention in the face of potentially disruptive circumstances.
|
|
|
•
|
Each NEO will only be eligible to receive severance payments if he or she signs a general release of claims following an eligible termination.
|
|
|
2015
|
2016
|
|
Name
|
Base Salary
|
Base Salary
|
|
Stephen G. Waldis
|
$591,165
|
$608,900
|
|
Karen L. Rosenberger
|
$330,000
|
$360,000
|
|
Robert E. Garcia
|
$437,091
|
$450,204
|
|
Christopher S. Putnam
|
$250,000
|
$340,000
|
|
Ronald J. Prague
|
$297,901
|
$315,000
|
|
Name
|
Target Incentive
Bonus Percentage
|
Maximum
Bonus Percentage
|
|
Stephen G. Waldis
|
110% of base salary
|
192.5% of base salary
|
|
Karen L. Rosenberger
|
60% of base salary
|
105% of base salary
|
|
Robert E. Garcia
|
80% of base salary
|
140% of base salary
|
|
Christopher S. Putnam
|
120% of base salary
|
140% of base salary
|
|
Ronald J. Prague
|
60% of base salary
|
105% of base salary
|
|
Corporate Component
|
Weighting
|
Threshold
25% payout
|
Target
100% payout
|
Maximum
175% payout
|
||||
|
Non-GAAP Revenue*
|
50
|
%
|
637,000,000
|
|
695,000,000
|
|
750,000,000
|
|
|
Non-GAAP EBITDA*
|
50
|
%
|
197,500,000
|
|
230,100,000
|
|
255,000,000
|
|
|
Corporate Component
|
Weighting
|
Achievement
|
Plan Payout
|
|||
|
Adjusted Non-GAAP Revenue
|
50
|
%
|
698,400,000
|
|
105
|
%
|
|
Adjusted Non-GAAP EBITDA
|
50
|
%
|
237,200,000
|
|
121
|
%
|
|
•
|
Mr. Waldis
received
100%
of target due to his integral role in leading our Company during the year through our strong growth, spearheading the Openwave and Intralinks acquisitions and leading our overall strategy.
|
|
•
|
Ms. Rosenberger
received
100%
of target due to her efforts in helping us achieve our continued strong financial performance and arranging and negotiating the financing required for the Intralinks Transaction.
|
|
•
|
Mr. Garcia
received
100%
of target due to his strong performance in ensuring our operations continued to perform well and, in particular, controlling costs throughout the organization.
|
|
•
|
Mr. Putnam
received
100%
of target due to his strong performance in leading our worldwide sales effort and leading the negotiations of several key customer deals.
|
|
•
|
Mr. Prague
received
100%
of target due to his strong performance in leading the negotiations of the Openwave and Intralinks acquisitions, continuing our strong patent program and assisting in the negotiation and closing of several key customer deals.
|
|
|
|
Target
|
|
Percentage of
|
|
Actual
|
|
Target
|
|
Individual
|
|
Actual
|
|
|
||||||||||
|
|
|
Bonus for
|
|
Corporate
|
|
Corporate
|
|
Bonus for
|
|
Objective
|
|
Individual
|
|
Total
|
||||||||||
|
|
|
Corporate
|
|
Component
|
|
Component
|
|
Individual
|
|
Performance
|
|
Component
|
|
Bonus
|
||||||||||
|
Executive
|
|
Component
|
|
Target Awarded
|
|
Awarded
|
|
Component
|
|
Percentage
|
|
Awarded
|
|
Awarded
|
||||||||||
|
Stephen G. Waldis
|
|
$
|
602,811
|
|
|
113%
|
|
$
|
681,176
|
|
|
$
|
66,979
|
|
|
100%
|
|
$
|
66,979
|
|
|
$
|
748,155
|
|
|
Karen L. Rosenberger
|
|
$
|
194,400
|
|
|
113%
|
|
$
|
219,672
|
|
|
$
|
21,600
|
|
|
100%
|
|
$
|
21,600
|
|
|
$
|
241,272
|
|
|
Robert E. Garcia
|
|
$
|
324,147
|
|
|
113%
|
|
$
|
366,286
|
|
|
$
|
36,016
|
|
|
100%
|
|
$
|
36,016
|
|
|
$
|
402,302
|
|
|
Christopher S. Putnam
|
|
$
|
—
|
|
|
—
|
|
$
|
—
|
|
|
$
|
408,000
|
|
|
100%
|
|
$
|
408,000
|
|
|
$
|
408,000
|
|
|
Ronald J. Prague
|
|
$
|
170,100
|
|
|
113%
|
|
$
|
192,213
|
|
|
$
|
18,900
|
|
|
100%
|
|
$
|
18,900
|
|
|
$
|
211,113
|
|
|
Name
|
|
Number of Time-Based
Shares of Restricted Stock
|
|
Number of Shares
Subject to Options
|
|
Stephen G. Waldis
|
|
52,951
|
|
133,043
|
|
Karen L. Rosenberger
|
|
12,915
|
|
32,449
|
|
Robert E. Garcia
|
|
32,287
|
|
81,124
|
|
Christopher S. Putnam
|
|
9,944
|
|
24,986
|
|
Ronald J. Prague
|
|
10,978
|
|
27,582
|
|
•
|
60% based on non-GAAP revenue growth of our Company;
|
|
•
|
30% based on our non-GAAP EBITDA; and
|
|
•
|
10% based on non-GAAP Cloud revenue.
|
|
|
Name
|
|
Threshold
|
|
Target
|
|
Maximum
|
|||
|
|
Stephen G. Waldis
|
|
8,634
|
|
|
17,267
|
|
|
34,535
|
|
|
|
Karen L. Rosenberger
|
|
2,046
|
|
|
4,091
|
|
|
8,183
|
|
|
|
Robert E. Garcia
|
|
5,659
|
|
|
11,319
|
|
|
22,637
|
|
|
|
Ronald J. Prague
|
|
1,279
|
|
|
2,557
|
|
|
5,115
|
|
|
|
Corporate Component
|
|
Threshold
50% payout
|
|
Target
100% payout
|
|
Maximum
200% payout
|
|
Weighting
|
|
|
Non-GAAP Revenue*
|
|
$667,100,000
|
|
$696,100,000
|
|
$725,100,000
|
|
60%
|
|
|
Non-GAAP EBITDA as % of Revenue*
|
|
25%
|
|
35%
|
|
45%
|
|
30%
|
|
|
Non-GAAP Cloud Revenue*
|
|
$388,400,000
|
|
$412,200,000
|
|
$436,000,000
|
|
10%
|
|
•
|
our Adjusted Non-GAAP revenue was
$698.4 million
, representing
20%
growth from
2015
, and above the target attainment, resulting in a
108%
payout with respect to this component;
|
|
•
|
our
2016
Adjusted Non-GAAP EBITDA was
$237.2 million
, or
34%
of revenue, representing
14%
growth from
2015
, and slightly below the target attainment, resulting in a
95%
payout with respect to this component; and
|
|
•
|
our
2016
non-GAAP Cloud revenue was
$403.4 million
, representing
27%
growth from
2015
, and slightly below the target threshold, resulting in a
81%
payout with respect to this component.
|
|
|
Corporate Component
|
|
Achievement
|
|
Plan Payout
|
|
Weighting
|
|
|
Adjusted Non-GAAP Revenue
|
|
$698,400,000
|
|
108%
|
|
60%
|
|
|
Adjusted Non-GAAP EBITDA
|
|
34%
|
|
95%
|
|
30%
|
|
|
Non-GAAP Cloud Revenue*
|
|
$403,381,000
|
|
81%
|
|
10%
|
|
Name
|
|
Performance
Shares Awarded
|
|
|
Stephen G. Waldis
|
|
17,509
|
|
|
Karen L. Rosenberger
|
|
4,148
|
|
|
Robert E. Garcia
|
|
11,477
|
|
|
Ronald J. Prague
|
|
2,593
|
|
|
Name
|
|
Threshold
|
|
Target
|
|
Maximum
|
|||
|
Stephen G. Waldis
|
|
26,476
|
|
|
52,951
|
|
|
105,902
|
|
|
Karen L. Rosenberger
|
|
6,476
|
|
|
12,915
|
|
|
25,748
|
|
|
Robert E. Garcia
|
|
16,144
|
|
|
32,287
|
|
|
64,574
|
|
|
Christopher S. Putnam
|
|
4,972
|
|
|
9,944
|
|
|
19,888
|
|
|
Ronald J. Prague
|
|
5,489
|
|
|
10,978
|
|
|
21,956
|
|
|
(1)
|
The material in this report is not "soliciting material," is not deemed "filed" with the SEC and is not to be incorporated by reference in any filing of Synchronoss Technologies, Inc. under the Securities Act or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.
|
|
Name and Principal Position
|
|
Year
|
|
Salary
($) |
|
Bonus
($) (1) |
|
Stock
Awards ($) (2) |
|
|
Option
Awards ($) (8) |
|
Non-Equity
Incentive Plan Compensation ($) (9) |
|
All Other
Compensation ($) |
|
|
Total
($) |
|||||||
|
Stephen G. Waldis
|
|
2016
|
|
608,900
|
|
|
66,979
|
|
|
3,069,569
|
|
(3)
|
|
1,261,248
|
|
|
681,176
|
|
|
20,074
|
|
(10)
|
|
5,707,946
|
|
|
|
|
2015
|
|
591,165
|
|
|
59,117
|
|
|
4,269,514
|
|
|
|
1,128,651
|
|
|
762,099
|
|
|
23,613
|
|
|
|
6,834,159
|
|
|
|
|
2014
|
|
573,947
|
|
|
57,395
|
|
|
2,879,044
|
|
|
|
1,429,622
|
|
|
903,966
|
|
|
33,051
|
|
|
|
5,877,025
|
|
|
Karen L. Rosenberger
|
|
2016
|
|
360,000
|
|
|
21,600
|
|
|
748,682
|
|
(4)
|
|
307,617
|
|
|
219,672
|
|
|
63,338
|
|
(11)
|
|
1,720,909
|
|
|
|
|
2015
|
|
330,000
|
|
|
29,700
|
|
|
1,011,634
|
|
|
|
267,436
|
|
|
212,709
|
|
|
19,704
|
|
|
|
1,871,183
|
|
|
|
|
2014
|
|
286,002
|
|
|
22,500
|
|
|
969,045
|
|
|
|
223,224
|
|
|
236,250
|
|
|
14,905
|
|
|
|
1,751,926
|
|
|
Robert E. Garcia
|
|
2016
|
|
450,204
|
|
|
36,016
|
|
|
1,871,677
|
|
(5)
|
|
769,056
|
|
|
366,286
|
|
|
17,150
|
|
(12)
|
|
3,510,389
|
|
|
|
|
2015
|
|
437,091
|
|
|
39,338
|
|
|
2,798,597
|
|
|
|
739,817
|
|
|
394,432
|
|
|
17,150
|
|
|
|
4,426,425
|
|
|
|
|
2014
|
|
424,360
|
|
|
38,192
|
|
|
2,395,400
|
|
|
|
899,514
|
|
|
467,857
|
|
|
17,000
|
|
|
|
4,242,323
|
|
|
Christopher S. Putnam
|
|
2016
|
|
340,000
|
|
|
408,000
|
|
|
576,454
|
|
(6)
|
|
236,867
|
|
|
—
|
|
|
7,950
|
|
(13)
|
|
1,569,271
|
|
|
Ronald J. Prague
|
|
2016
|
|
315,000
|
|
|
18,900
|
|
|
736,408
|
|
(7)
|
|
261,477
|
|
|
192,213
|
|
|
7,950
|
|
(13)
|
|
1,531,948
|
|
|
(1)
|
The amounts set forth in this column represent the subjective individual component portion of our annual cash incentive bonus awards paid to the NEOs. See "
Compensation Discussion and Analysis
" above for further discussion of the subjective individual component.
|
|
(2)
|
The amounts in this column reflect the grant date fair value, computed in accordance with FASB ASC Topic No. 718, of the performance share awards (with the grant date fair value determined using the probable outcome of the performance conditions) and the time-based restricted share award granted to our NEOs. See "
Compensation Discussion and Analysis
" above for further discussion of these share awards. See Footnote 2 to the Financial Statements included in our Annual Report on Form 10-K for the year ended
December 31, 2016
for a discussion of our assumptions in estimating the fair value of our share awards. Our executive officers will not realize any value of these awards until these awards are sold.
|
|
(3)
|
The grant date value of the performance-based restricted share award assuming the highest level of performance conditions is achieved was
$3,405,808
.
|
|
(4)
|
The grant date value of the performance-based restricted share award assuming the highest level of performance conditions is achieved was
$828,056
.
|
|
(5)
|
The grant date value of the performance-based restricted share award assuming the highest level of performance conditions is achieved was
$2,076,700
.
|
|
(6)
|
The grant date value of the performance-based restricted share award assuming the highest level of performance conditions is achieved was
$639,598
.
|
|
(7)
|
The grant date value of the performance-based restricted share award assuming the highest level of performance conditions is achieved was
$706,105
.
|
|
(8)
|
The amounts in this column reflect the grant date fair value, computed in accordance with FASB ASC Topic No. 718, of option awards granted to our NEOs. See Footnote 2 to the Financial Statements included in our Annual Report on Form 10-K for the year ended
December 31, 2016
for a discussion of our assumptions in estimating the fair value of our stock option awards. Our NEOs will not realize any value with respect to these awards until these awards are exercised or sold.
|
|
(9)
|
The amounts under this column include amounts paid based on the objective corporate component of the Company's annual incentive bonus compensation plan described under "
Compensation Discussion and Analysis
" above.
|
|
(10)
|
Reflects amounts paid for leasing an automobile, including insurance premiums, and Company paid 401(k) matching contribution.
|
|
(11)
|
Reflects (i) $13,571 paid for leasing an automobile, including insurance premiums, (ii) commuting expenses of $41,817 related to travel between Mr. Rosenberger's home and our Company headquarters for lodging, and (iii) Company paid 401(k) matching contributions.
|
|
(12)
|
Reflects amounts paid for a car allowance (including insurance), and Company paid 401(k) matching contribution.
|
|
(13)
|
Reflects Company paid 401(k) matching contribution.
|
|
|
|
|
|
Estimated Future Payouts
Under Non-Equity Incentive Plan
Awards (1)
|
|
Estimated Future Payouts Under Equity Incentive Plan Awards (2)
|
|
|
All Other Stock Awards: Number
of
Shares
of Stock
or Units
(#) (3)
|
|
|
All Other Option Awards: Number of Securities Underlying
Options
(#) (4)
|
|
|
Exercise
or Base
Price of
Option
Awards
($/Sh)
|
|
Value of
Stock and
Option
Awards
($) (5)
|
||||||||||||||||||
|
Name
|
|
Grant Date
|
|
Threshold
($)
|
|
Target
($)
|
|
Maximum
($)
|
|
Threshold
(#)
|
|
Target
(#)
|
|
Maximum
(#)
|
|
|
|
|
|
|
|
||||||||||||||
|
Stephen G. Waldis
|
|
|
|
150,703
|
|
|
602,811
|
|
|
1,054,919
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
2/19/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
133,043
|
|
|
|
25.81
|
|
|
1,261,248
|
|
|||||||
|
|
|
2/19/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
52,951
|
|
|
|
|
|
|
|
|
1,366,665
|
|
||||||||
|
|
|
2/19/2016
|
|
|
|
|
|
|
|
26,476
|
|
|
52,951
|
|
|
105,902
|
|
|
|
|
|
|
|
|
|
|
|
1,702,904
|
|
||||||
|
Karen L. Rosenberger
|
|
|
|
48,600
|
|
|
194,400
|
|
|
340,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
2/19/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32,449
|
|
|
|
25.81
|
|
|
307,617
|
|
|||||||
|
|
|
2/19/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,915
|
|
|
|
|
|
|
|
|
333,336
|
|
||||||||
|
|
|
2/19/2016
|
|
|
|
|
|
|
|
6,476
|
|
|
12,915
|
|
|
25,748
|
|
|
|
|
|
|
|
|
|
|
|
415,346
|
|
||||||
|
Robert E. Garcia
|
|
|
|
81,037
|
|
|
324,147
|
|
|
567,257
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
2/19/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
81,124
|
|
|
|
25.81
|
|
|
769,056
|
|
|||||||
|
|
|
2/19/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32,287
|
|
|
|
|
|
|
|
|
833,327
|
|
||||||||
|
|
|
2/19/2016
|
|
|
|
|
|
|
|
16,144
|
|
|
32,287
|
|
|
64,574
|
|
|
|
|
|
|
|
|
|
|
|
1,038,350
|
|
||||||
|
Christopher S. Putnam
|
|
|
|
91,800
|
|
|
367,200
|
|
|
642,600
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
2/19/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24,986
|
|
|
|
25.81
|
|
|
236,867
|
|
|||||||
|
|
|
2/19/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,944
|
|
|
|
|
|
|
|
|
256,655
|
|
||||||||
|
|
|
2/19/2016
|
|
|
|
|
|
|
|
4,972
|
|
|
9,944
|
|
|
19,888
|
|
|
|
|
|
|
|
|
|
|
|
319,799
|
|
||||||
|
Ronald J. Prague
|
|
|
|
42,525
|
|
|
170,100
|
|
|
297,675
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
2/19/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27,582
|
|
|
|
25.81
|
|
|
261,477
|
|
|||||||
|
|
|
1/27/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,388
|
|
|
|
|
|
|
|
|
100,014
|
|
||||||||
|
|
|
2/19/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,978
|
|
|
|
|
|
|
|
|
283,342
|
|
||||||||
|
|
|
2/19/2016
|
|
|
|
|
|
|
|
5,489
|
|
|
10,978
|
|
|
21,956
|
|
|
|
|
|
|
|
|
|
|
|
353,052
|
|
||||||
|
(1)
|
Each of our NEOs was granted a non-equity incentive plan award pursuant to our
2016
annual incentive bonus compensation plan. The amounts shown in the "Threshold" column reflect the cash payment that would have been awarded under our
2016
annual incentive bonus plan if we had achieved the threshold payout level for a single corporate objective with the lowest weight. The amounts shown in the "Target" column reflect the target payment level under our
2016
annual incentive bonus plan if we had achieved all of the objectives previously approved by our Compensation Committee at target levels. The amounts shown in the "Maximum" column reflect the maximum payouts under our
2016
annual incentive bonus compensation plan if we had achieved all of the objectives previously approved by our Compensation Committee at or above the maximum level. The corporate and business components of our
2016
annual incentive bonus compensation plan are discussed in greater detail in "
Compensation Discussion and Analysis
" above. The actual amounts paid to each NEO are shown in the Summary Compensation Table above. The table does not include the individual discretionary component portion of the NEOs' aggregate targeted annual cash incentive bonus amount.
|
|
(2)
|
Reflects
2016
-
2018
Performance Shares as described in greater detail in "
Compensation Discussion and Analysis
" above. The amounts shown in the "threshold" column reflect the
2016
-
2018
Performance Shares that will be earned if certain minimum financial goals are achieved. The amounts shown in the "target" column reflect the number of
2016
-
2018
Performance Shares that will be earned if all of the
2016
-
2018
financial goals are achieved at target levels. The amounts shown in the "maximum" column reflect the maximum number of
2016
-
2018
Performance Shares that can be earned if all of the
2016
-2018 financial goals are achieved at or above maximum levels
.
|
|
(3)
|
One-third of the restricted shares vested on February 19, 2017 and one-third of the restricted shares vest on each of February 19, 2018 and 2019, provided that the recipient remains continuously employed by our Company through each such date except that with, respect to Mr. Prague's January 27, 2016 grant of restricted shares, one-half of the shares vested on January 27, 2017 and the remaining one-half will vest on January 27, 2018, subject to Mr. Prague's continued service to the Company.
|
|
(4)
|
The options vest over four years from the vesting start date of February 19, 2016, with 25% of the shares vesting after the completion of the first year of service to the Company and the remaining shares vesting in equal monthly installments over an additional 36 months of continuous service to the Company. As a result, the option will be fully exercisable on February 19, 2020.
|
|
(5)
|
The amount in this column reflects the grant date fair value, computed in accordance with FASB ASC Topic No. 718, of stock awards and options granted to our NEOs. See Footnote 2 to the Financial Statements included in our Annual Report on Form 10-K for the year ended December 31,
2016
for a discussion of our assumptions in estimating the fair value of our stock and option awards.
|
|
|
•
|
|
Stephen G. Waldis:
On February 19, 2016, we granted Mr. Waldis (i) an option to purchase 133,043 shares of our Common Stock, (ii) 52,951 time-based restricted shares of our Common Stock, and (iii) a target award of 52,951 2016-2018 Performance Shares, which are earned based on our Company's achievement of performance metrics discussed in the
Compensation Discussion and Analysis
section of this Proxy Statement for the 2016-2018 Performance Shares. On January 31, 2017, our Company issued 17,509 of the 2015-2016 Performance Shares to Mr. Waldis based on our Company's 2016 financial performance.
|
|
|
•
|
|
Karen L. Rosenberger:
On February 19, 2016, we granted Ms. Rosenberger (i) an option to purchase 32,449 shares of our Common Stock, (ii) 12,915 time-based restricted shares of our Common Stock, and (iii) a target award of 12,915 2016-2018 Performance Shares, which are earned based on our Company's achievement of performance metrics discussed in the
Compensation Discussion and Analysis
section of this Proxy Statement for the 2016-2018 Performance Shares. On January 31, 2017, our Company issued 4,148 of the 2015-2016 Performance Shares to Ms. Rosenberger based on our Company's 2016 financial performance.
|
|
|
•
|
|
Robert E. Garcia:
On February 19, 2016, we granted Mr. Garcia (i) an option to purchase 81,124 shares of our Common Stock, (ii) 32,287 time-based restricted shares of our Common Stock, and (iii) a target award of 32,287 2016-2018 Performance Shares, which are earned based on the Company's achievement of performance metrics discussed in the
Compensation Discussion and Analysis
section of this Proxy Statement for the 2016-2018 Performance Shares. On January 31, 2017, our Company issued 11,477 of the 2015-2016 Performance Shares to Mr. Garcia based on our Company's 2016 financial performance.
|
|
|
•
|
|
Christopher S. Putnam:
On February 19, 2016, we granted Mr. Putnam (i) an option to purchase 24,986 shares of our Common Stock, (ii) 9,944 time-based restricted shares of our Common Stock, and (iii) a target award of 9,944 2016-2018 Performance Shares, which are earned based on achievement of our Company's performance metrics discussed in the
Compensation Discussion and Analysis
section of this Proxy Statement for the 2016-2018 Performance Shares.
|
|
|
•
|
|
Ronald J. Prague:
On February 19, 2016, we granted Mr. Prague (i) an option to purchase 27,582 shares of our Common Stock, (ii) 10,978 time-based restricted shares of our Common Stock, and (iii) a target award of 10,978 2016-2018 Performance Shares, which are earned based on achievement of our Company's performance metrics discussed in the
Compensation Discussion and Analysis
section of this Proxy Statement for the 2016-2018 Performance Shares. On January 27, 2016, as a special one-time award for successfully negotiating several key customer agreements, we granted Mr. Prague 3,388 restricted shares of our Common Stock. On January 31, 2017, our Company issued 2,593 of the 2015-2016 Performance Shares to Mr. Prague based on our Company's 2016 financial performance.
|
|
|
|
Option Awards
|
|
Stock Awards
|
|||||||||||||||||||||||
|
Name
|
|
Number of
Securities
Underlying
Unexercised
Options (#)
Exercisable
|
|
|
Number of
Securities
Underlying
Unexercised
Options (#)
Unexercisable
|
|
|
Option
Exercise
Price
($)
|
|
Option
Expiration
Date
|
|
Number of Shares or Units of Stock That Have Not Vested
(#)
|
|
|
Market Value of Shares or Units of Stock That Have Not
Vested
($)(1)
|
|
Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested
(#)
|
|
|
Equity Incentive Plan Awards: Market or Payout Value
of Unearned Shares, Units or Other Rights That Have Not Vested
(#)(26)
|
|||||||
|
Stephen G. Waldis
|
|
79,440
|
|
(2)
|
|
—
|
|
|
|
27.55
|
|
|
12/07/2017
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
160,000
|
|
(3)
|
|
—
|
|
|
|
30.50
|
|
|
12/06/2018
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
73,217
|
|
(4)
|
|
3,183
|
|
|
|
31.02
|
|
|
02/14/2020
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
61,918
|
|
(5)
|
|
25,495
|
|
|
|
32.40
|
|
|
02/13/2021
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
32,334
|
|
(6)
|
|
38,212
|
|
|
|
41.37
|
|
|
02/09/2022
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
—
|
|
|
|
133,043
|
|
(11)
|
|
25.81
|
|
|
02/19/2023
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
13,497
|
|
(13)
|
|
516,935
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
16,872
|
|
(14)
|
|
646,198
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
17,267
|
|
(15)
|
|
661,326
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
52,951
|
|
(16)
|
|
2,028,023
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
105,902
|
|
(22)
|
|
4,056,047
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
51,802
|
|
(23)
|
|
1,984,017
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34,535
|
|
(24)
|
|
1,322,691
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,951
|
|
(25)
|
|
496,023
|
|
|||||
|
Karen L. Rosenberger
|
|
—
|
|
|
|
167
|
|
(4)
|
|
31.02
|
|
|
02/14/2020
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
—
|
|
|
|
1,563
|
|
(12)
|
|
32.24
|
|
|
02/20/2021
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
422
|
|
(7)
|
|
2,547
|
|
|
|
35.19
|
|
|
04/01/2021
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
7,662
|
|
(6)
|
|
9,054
|
|
|
|
41.37
|
|
|
02/09/2022
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
—
|
|
|
|
32,449
|
|
(11)
|
|
25.81
|
|
|
02/19/2023
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
770
|
|
(17)
|
|
29,491
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
8,451
|
|
(13)
|
|
323,673
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
1,040
|
|
(14)
|
|
39,832
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
4,091
|
|
(15)
|
|
156,685
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
12,915
|
|
(16)
|
|
494,645
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,748
|
|
(22)
|
|
986,148
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,274
|
|
(23)
|
|
470,094
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,183
|
|
(24)
|
|
313,409
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,069
|
|
(25)
|
|
117,543
|
|
|||||
|
Robert E. Garcia
|
|
6,310
|
|
(3)
|
|
—
|
|
|
|
30.50
|
|
|
12/06/2018
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
7,500
|
|
(8)
|
|
—
|
|
|
|
30.11
|
|
|
01/03/2019
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
19,166
|
|
(4)
|
|
1,667
|
|
|
|
31.02
|
|
|
02/14/2020
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
25,208
|
|
(5)
|
|
16,042
|
|
|
|
32.40
|
|
|
02/13/2021
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
21,195
|
|
(6)
|
|
25,047
|
|
|
|
41.37
|
|
|
02/09/2022
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
—
|
|
|
|
81,124
|
|
(11)
|
|
25.81
|
|
|
02/19/2023
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
9,000
|
|
(13)
|
|
344,700
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
11,250
|
|
(14)
|
|
430,875
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
11,318
|
|
(15)
|
|
433,479
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
32,287
|
|
(16)
|
|
1,236,592
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
64,574
|
|
(22)
|
|
2,473,184
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33,956
|
|
(23)
|
|
1,300,515
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22,637
|
|
(24)
|
|
866,997
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,489
|
|
(25)
|
|
325,129
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Christopher S. Putnam
|
|
1,211
|
|
(9)
|
|
1,696
|
|
|
|
50.31
|
|
04/15/2022
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
4,905
|
|
(10)
|
|
13,204
|
|
|
|
36.06
|
|
11/13/2022
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
—
|
|
|
|
24,986
|
|
(11)
|
|
25.81
|
|
02/19/2023
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
6,250
|
|
(18)
|
|
239,375
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
712
|
|
(19)
|
|
27,270
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
6,000
|
|
(20)
|
|
229,800
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
9,944
|
|
(16)
|
|
380,855
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19,888
|
|
(22)
|
|
761,710
|
|
|||||
|
Ronald J. Prague
|
|
13,700
|
|
(2)
|
|
—
|
|
|
|
27.55
|
|
|
12/07/2017
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
8,000
|
|
(3)
|
|
—
|
|
|
|
30.50
|
|
|
12/06/2018
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
9,296
|
|
(4)
|
|
404
|
|
|
|
31.02
|
|
|
02/14/2020
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
9,563
|
|
(5)
|
|
3,937
|
|
|
|
32.40
|
|
|
02/13/2021
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
4,788
|
|
(6)
|
|
5,659
|
|
|
|
41.37
|
|
|
02/09/2022
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
—
|
|
|
|
27,582
|
|
(11)
|
|
25.81
|
|
|
02/19/2023
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
2,000
|
|
(13)
|
|
76,600
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
2,500
|
|
(14)
|
|
95,750
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
2,557
|
|
(15)
|
|
97,933
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
3,388
|
|
(21)
|
|
129,760
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
10,978
|
|
(16)
|
|
420,457
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21,956
|
|
(22)
|
|
840,915
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,672
|
|
(23)
|
|
293,838
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,115
|
|
(24)
|
|
195,905
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,918
|
|
(25)
|
|
73,459
|
|
|||||
|
(1)
|
Computed in accordance with SEC rules as the number of unvested shares multiplied by the closing market price per share of our Common Stock on December 30, 2016, which was the last trading day of 2016, which was
$38.30
per share. The actual value (if any) to be realized by the NEO depends on whether the shares vest and the future performance of our Common Stock. Each of the options and restricted shares automatically vest if we are acquired and the NEO is either involuntarily terminated or voluntarily resigns for good reason under certain circumstances following our change of control, as discussed in more detail below under "
Employment Agreements
."
|
|
(2)
|
This option vested over four years of continuous service following December 7, 2010, with 25% vesting after the first year of service and the remaining shares vesting in equal monthly installments over an additional 36 months of continuous service. As a result, this option is fully exercisable.
|
|
(3)
|
The option vested over four years of continuous service following December 6, 2011, with 25% vesting after the first year of service and the remaining shares vesting in equal monthly installments over an additional 36 months of continuous service. As a result, the option is fully exercisable.
|
|
(4)
|
The option vested over four years of continuous service following February 14, 2013, with 25% vesting after the first year of service and the remaining shares vesting in equal monthly installments over an additional 36 months of continuous service. As a result, the option became fully exercisable on February 14, 2017.
|
|
(5)
|
The option vests over four years from the vesting start date of February 13, 2014, with 25% vesting after the completion of the first year of service to the Company and the remaining shares vesting in equal monthly installments over an additional 36 months of continuous service to the Company. As a result, the option will be fully exercisable on February 13, 2018.
|
|
(6)
|
The option vests over four years of continuous service following February 9, 2015, with 25% vesting after the first year of service and the remaining shares vesting in equal monthly installments over an additional 36 months of continuous service. As a result, the option will be fully exercisable on February 9, 2019.
|
|
(7)
|
The option vests over four years of continuous service following April 1, 2014, with 25% vesting after the first year of service and the remaining shares vesting in equal monthly installments over an additional 36 months of continuous service. As a result, the option will be fully exercisable on April 1, 2018.
|
|
(8)
|
The option vested over four years of continuous service following January 3, 2012, with 25% vesting after the first year of service and the remaining shares vesting in equal monthly installments over an additional 36 months of continuous service. As a result, the option is fully exercisable.
|
|
(9)
|
The option vests over four years of continuous service following April 15, 2015, with 25% vesting after the first year of service and the remaining shares vesting in equal monthly installments over an additional 36 months of continuous service. As a result, the option will be fully exercisable on April 15, 2019.
|
|
(10)
|
The option vests over four years of continuous service following November 13, 2015, with 25% vesting after the first year of service and the remaining shares vesting in equal monthly installments over an additional 36 months of continuous service. As a result, the option will be fully exercisable on November 13, 2019.
|
|
(11)
|
The option vests over four years of continuous service following February 19, 2016, with 25% vesting after the first year of service and the remaining shares vesting in equal monthly installments over an additional 36 months of continuous service. As a result, the option will be fully exercisable on February 19, 2020.
|
|
(12)
|
The option vested over four years of continuous service following February 20, 2014, with 25% vesting after the first year of service and the remaining shares vesting in equal monthly installments over an additional 36 months of continuous service. As a result, the option will be fully exercisable on February 20, 2018.
|
|
(13)
|
Reflects restricted shares granted on February 13, 2014. These shares vested on February 13, 2017.
|
|
(14)
|
Reflects performance-based restricted shares awarded on February 13, 2014 and earned (based on our 2014 financial performance) on January 29, 2015. These shares vested on February 13, 2017.
|
|
(15)
|
Reflects restricted shares granted on February 9, 2015. One-half of the shares vested on February 9, 2017 and one-half of the shares will vest on February 9, 2018, provided the NEO remains continuously employed by the Company on that date.
|
|
(16)
|
Reflects restricted shares granted on February 19, 2016. One-third of the shares vested on February 9, 2017 and one-third of the shares will vest on each of February 19, 2018 and 2019, provided the NEO remains continuously employed by the Company on those dates.
|
|
(17)
|
Reflects restricted shares vesting over four years of continuous service following February 20, 2014, with 25% of the shares vesting after the first year of service and the remaining shares vesting ratably on a quarterly basis thereafter, provided the NEO remains continuously employed by the Company. As a result, the shares will fully vest on February 20, 2018.
|
|
(18)
|
Reflects restricted shares vesting over four years of continuous service following November 1, 2013, with 25% of the shares vesting after the first year of service and the remaining shares vesting ratably on a quarterly basis thereafter, provided the NEO remains continuously employed by the Company. As a result, the shares will fully vest on November 1, 2017.
|
|
(19)
|
Reflects restricted shares granted on April 15, 2015. One-half of the shares vested on February 17, 2017 and the remaining one-half of the shares will vest on February 17, 2018, provided the NEO remains continuously employed by our Company on that date.
|
|
(20)
|
Reflects restricted shares vesting over four years of continuous service following November 13, 2015, with 25% of the shares vesting after the first year of service and the remaining shares vesting ratably on a quarterly basis thereafter, provided the NEO remains continuously employed by the Company through those dates. As a result, the shares will fully vest on November 15, 2015.
|
|
(21)
|
Reflects restricted shares granted on January 27, 2016. One-half of the shares vested on January 27, 2017 and the remaining one-half of the shares will vest on January 27, 2018, provided the NEO remains continuously employed by our Company on that date.
|
|
(22)
|
Each NEO was awarded a 2016-2018 performance-based restricted share award that is earned upon our Company's achievement of certain financial objectives for the three-year period from 2016 to 2018 (as described in greater detail in "
Compensation Discussion and Analysis
" above). The amount shown reflects the maximum award if all of the associated performance metrics are achieved. The actual number of shares earned will be determined in January 2019, at which time the shares will be fully vested.
|
|
(23)
|
Each NEO employed by our Company on February 19, 2015 was awarded a 2015-2017 performance-based restricted share award that vests upon our Company's achievement of certain financial objectives for the three-year period from 2015 to 2017. The amount shown reflects the maximum award if all of the associated performance metrics are achieved. The actual number of shares earned will be determined in January 2018, at which time the shares will be fully vested.
|
|
(24)
|
Each individual who was an executive officer as of February 9, 2015 was awarded a 2015-2016 performance-based restricted share award (as described in greater detail in "
Compensation Discussion and Analysis
" above). The amount shown reflects the maximum award if all of the associated performance metrics were achieved for the fiscal year ended December 31, 2016. The actual number of shares earned was determined in January 2017 and is shown in the table below. These shares became fully vested when that determination was made.
|
|
Name of Recipient
|
|
Number of Shares
|
|
Stephen G. Waldis
|
|
17,509
|
|
Karen L. Rosenberger
|
|
4,148
|
|
Robert E. Garcia
|
|
11,477
|
|
Ronald J. Prague
|
|
2,593
|
|
|
|
Option Awards
|
|
Stock Awards
|
||||||||
|
Name
|
|
Number of Shares Acquired on
Exercise (#)
|
|
Value Realized on Exercise ($) (1)
|
|
Number of Shares Acquired on
Vesting (#)
|
|
Value Realized on Vesting ($) (1)
|
||||
|
Stephen G. Waldis
|
|
62,860
|
|
|
966,556
|
|
|
68,022
|
|
|
1,699,706
|
|
|
Karen L. Rosenberger
|
|
10,000
|
|
|
72,140
|
|
|
13,629
|
|
|
422,926
|
|
|
Robert E. Garcia
|
|
7,440
|
|
|
62,303
|
|
|
43,858
|
|
|
1,108,037
|
|
|
Christopher S. Putnam
|
|
—
|
|
|
—
|
|
|
13,607
|
|
|
439,947
|
|
|
Ronald J. Prague
|
|
—
|
|
|
—
|
|
|
9,762
|
|
|
244,420
|
|
|
Name
|
|
Benefit
|
|
Voluntary
Resignation/
Termination
for Cause
($)
|
|
Involuntary
Termination
Prior to, or More
Than 24 Months
after, a Change
in Control
($)
|
|
Termination
Due to
Death or
Disability
($)
|
|
|
Involuntary
Termination
Within 24 Months
After a Change
in Control
($)
|
||||||||
|
Stephen G. Waldis
|
|
Severance (1)
|
|
$
|
—
|
|
|
$
|
3,000,377
|
|
|
$
|
669,790
|
|
|
|
$
|
3,603,188
|
|
|
|
|
Option Acceleration (2)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
1,835,300
|
|
||||
|
|
|
Restricted Stock Acceleration (3)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
4,561,415
|
|
||||
|
|
|
Accrued Vacation (4)
|
|
11,710
|
|
|
11,710
|
|
|
11,710
|
|
|
|
11,710
|
|
||||
|
|
|
Benefit Continuation (5)
|
|
—
|
|
|
30,168
|
|
|
30,168
|
|
(6)
|
|
30,168
|
|
||||
|
|
|
Total Value
|
|
$
|
11,710
|
|
|
$
|
3,042,255
|
|
|
$
|
711,668
|
|
|
|
$
|
10,041,781
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Karen L. Rosenberger
|
|
Severance (1)
|
|
$
|
—
|
|
|
$
|
790,580
|
|
|
$
|
216,000
|
|
|
|
$
|
1,221,159
|
|
|
|
|
Option Acceleration (2)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
423,897
|
|
||||
|
|
|
Restricted Stock Acceleration (3)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
1,212,310
|
|
||||
|
|
|
Accrued Vacation (4)
|
|
6,923
|
|
|
6,923
|
|
|
6,923
|
|
|
|
6,923
|
|
||||
|
|
|
Benefit Continuation (5)
|
|
—
|
|
|
29,976
|
|
|
29,976
|
|
(6)
|
|
29,976
|
|
||||
|
|
|
Total Value
|
|
$
|
6,923
|
|
|
$
|
827,479
|
|
|
$
|
252,899
|
|
|
|
$
|
2,894,265
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Robert E. Garcia
|
|
Severance (1)
|
|
$
|
—
|
|
|
$
|
1,145,216
|
|
|
$
|
360,163
|
|
|
|
$
|
1,840,227
|
|
|
|
|
Option Acceleration (2)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
1,120,022
|
|
||||
|
|
|
Restricted Stock Acceleration (3)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
2,910,379
|
|
||||
|
|
|
Accrued Vacation (4)
|
|
8,658
|
|
|
8,658
|
|
|
8,658
|
|
|
|
8,658
|
|
||||
|
|
|
Benefit Continuation (5)
|
|
—
|
|
|
27,480
|
|
|
27,480
|
|
(6)
|
|
27,480
|
|
||||
|
|
|
Total Value
|
|
$
|
8,658
|
|
|
$
|
1,181,354
|
|
|
$
|
396,301
|
|
|
|
$
|
5,906,766
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Christopher S. Putnam
|
|
Severance (1)
|
|
$
|
—
|
|
|
$
|
772,500
|
|
|
$
|
408,000
|
|
|
|
$
|
1,205,000
|
|
|
|
|
Option Acceleration (2)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
341,652
|
|
||||
|
|
|
Restricted Stock Acceleration (3)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
877,300
|
|
||||
|
|
|
Accrued Vacation (4)
|
|
6,538
|
|
|
6,538
|
|
|
6,538
|
|
|
|
6,538
|
|
||||
|
|
|
Benefit Continuation (5)
|
|
—
|
|
|
27,872
|
|
|
27,872
|
|
(6)
|
|
27,872
|
|
||||
|
|
|
Total Value
|
|
$
|
6,538
|
|
|
$
|
806,910
|
|
|
$
|
442,410
|
|
|
|
$
|
2,458,362
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Ronald J. Prague
|
|
Severance (1)
|
|
$
|
—
|
|
|
$
|
758,133
|
|
|
$
|
189,000
|
|
|
|
$
|
1,201,265
|
|
|
|
|
Option Acceleration (2)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
370,669
|
|
||||
|
|
|
Restricted Stock Acceleration (3)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
925,481
|
|
||||
|
|
|
Accrued Vacation (4)
|
|
6,058
|
|
|
6,058
|
|
|
6,058
|
|
|
|
6,058
|
|
||||
|
|
|
Benefit Continuation (5)
|
|
—
|
|
|
29,976
|
|
|
29,976
|
|
(6)
|
|
29,976
|
|
||||
|
|
|
Total Value
|
|
$
|
6,058
|
|
|
$
|
794,167
|
|
|
$
|
225,034
|
|
|
|
$
|
2,533,449
|
|
|
(1)
|
For purposes of valuing cash severance payments in the table above, we used each executive officer's base salary as of
December 31, 2016
. For purposes of calculating cash severance payments in the table above in the event of an involuntary termination (whether prior to, within 24 months following, or more than 24 months following, a change in control), we used each NEO’s average annual bonuses for
2014
and
2015
and, for purposes of calculating cash severance payments in the table above in the event of a termination due to permanent disability, we used the NEO’s target bonus as of
December 31, 2016
.
|
|
(2)
|
The value of option acceleration shown in the table above was calculated based on the assumption that the triggering event occurred on
December 31, 2016
. The value of the vesting acceleration was calculated by multiplying the number of unvested shares subject to each option by the excess of the closing price of our Common Stock on
December 30, 2016
, the last trading day of the year, over the exercise price of the option.
|
|
(3)
|
The value of restricted stock acceleration shown in the table above was calculated based on the assumption that the triggering event occurred on
December 31, 2016
. The value of the vesting acceleration was calculated by multiplying the number of unvested shares subject to each restricted stock grant by the closing price of our Common Stock on
December 30, 2016
, the last trading day of the year.
|
|
(4)
|
Based on each executive officer's base salary in effect and the number of each NEO's accrued but unused vacation days as of
December 31, 2016
.
|
|
(5)
|
Amounts reflect two times the current cost to us of the individual's health and welfare benefits per year.
|
|
(6)
|
Only payable in the event of a termination due to permanent disability.
|
|
Plan Category
|
|
Number of Securities
to be Issued Upon
Exercise of
Outstanding Options Warrants
and Rights
(a)
|
|
Weighted-Average
Exercise Price of
Outstanding
Options Warrants and Rights
(b)
|
|
Number of Securities
for Future Issuance
Under Equity
Compensation Plans
(Excluding Securities
Reflected in Column (a))
(c)
|
||||||
|
Equity compensation plans approved by security holders
|
|
2,329,353
|
|
(1)
|
|
$
|
|
|
|
2,293,712
|
|
(2)
|
|
Equity compensation plans not approved by security holders
(3)
|
|
3,775
|
|
|
|
19.32
|
|
|
—
|
|
|
|
|
Total
|
|
2,333,128
|
|
|
|
$
|
32.46
|
|
|
2,293,712
|
|
|
|
(1)
|
In addition, as of December 31,
2016
, there were
1,918,437
shares of unvested restricted common stock outstanding, which shares are subject to the risk of forfeiture if the underlying time-based or performance-based vesting conditions are not satisfied.
|
|
(2)
|
As of March, 27 2017, there were 3,458,574 shares available for issuance under the 2015 Equity Incentive Plan, which includes shares that were assumed from the Intralinks Holdings, Inc. 2010 Equity Incentive Plan in connection with the consummation of the Intralinks Transaction.
|
|
(1)
|
The material in this report is not "soliciting material," is not deemed "filed" with the SEC and is not to be incorporated by reference in any filing of Synchronoss Technologies, Inc. under the Securities Act or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.
|
|
|
Name of Beneficial Owner (*)
|
|
Beneficially
Owned (1)
|
|
|
|
Percent (2)
|
||
|
|
Executive Officers and Directors:
|
|
|
|
|
|
|
||
|
|
Ronald W. Hovsepian
|
|
54,780
|
|
|
(3
|
)
|
|
**
|
|
|
Stephen G. Waldis
|
|
843,943
|
|
|
(4
|
)
|
|
1.8%
|
|
|
James M. McCormick
|
|
3,109,859
|
|
|
(5
|
)
|
|
6.7%
|
|
|
William J. Cadogan
|
|
329,150
|
|
|
(6
|
)
|
|
**
|
|
|
Thomas J. Hopkins
|
|
77,597
|
|
|
(7
|
)
|
|
**
|
|
|
Donnie M. Moore
|
|
65,390
|
|
|
(8
|
)
|
|
**
|
|
|
John DeFeo
|
|
12,850
|
|
|
(9
|
)
|
|
**
|
|
|
John W. Frederick
|
|
53,971
|
|
|
(10
|
)
|
|
**
|
|
|
Robert E. Garcia
|
|
214,282
|
|
|
(11
|
)
|
|
**
|
|
|
Ronald J. Prague
|
|
108,187
|
|
|
(12
|
)
|
|
**
|
|
|
Christopher S. Putnam
|
|
33,287
|
|
|
(13
|
)
|
|
**
|
|
|
Karen L. Rosenberger
|
|
52,489
|
|
|
(14
|
)
|
|
**
|
|
|
All executive officers and directors as a group (12 persons)
|
|
4,955,785
|
|
|
(15
|
)
|
|
10.5%
|
|
|
Stockholders owning approximately 5% or more
:
|
|
|
|
|
|
|
||
|
|
BlackRock, Inc., 55 East 52nd Street, New York, NY 10055
|
|
4,693,868
|
|
|
(16
|
)
|
|
10.1%
|
|
|
FMR LLC, 82 Devonshire Street, Boston, MA 02109
|
|
3,217,995
|
|
|
(17
|
)
|
|
7.1%
|
|
|
The Vanguard Group, 100 Vanguard Blvd., Malvern, PA 19355
|
|
3,504,259
|
|
|
(18
|
)
|
|
7.6%
|
|
(1)
|
Represents sum of shares owned and shares that may be purchased upon exercise of options exercisable within 60 days of
March 27, 2017
.
|
|
(2)
|
Any shares not outstanding that are subject to options exercisable within 60 days of
March 27, 2017
are deemed outstanding for the purpose of computing the percentage of outstanding shares owned by any person holding such shares but are not deemed outstanding for the purpose of computing the percentage of shares owned by any other person.
|
|
(3)
|
Includes 54,780 shares of restricted common stock subject to the Company's lapsing right of repurchase. Excludes 156,515 shares subject to options not exercisable within 60 days of
March 27, 2017
.
|
|
(4)
|
Includes 87,173 shares of restricted common stock subject to the Company's lapsing right of repurchase. Includes 468,121 shares subject to options exercisable within 60 days of
March 27, 2017
. Excludes 262,266 shares subject to options not exercisable within 60 days of
March 27, 2017
.
|
|
(5)
|
Includes 870,000 shares held by Vertek Corporation, of which Mr. McCormick is the Chief Executive Officers and sole stockholder. Mr. McCormick exercises sole voting and dispositive power with respect to these shares. Includes 8,125 shares of restricted common stock subject to the Company's lapsing right of repurchase. Includes 37,172 shares subject to options exercisable within 60 days of
March 27, 2017
. Excludes 15,654 shares subject to options not exercisable within 60 days of
March 27, 2017
.
|
|
(6)
|
Includes 8,125 shares of restricted common stock subject to the Company's lapsing right of repurchase. Includes 50,000 shares held by Barbara Cadogan, Mr. Cadogan's wife. Includes 37,172 shares subject to options exercisable within 60 days of March 23, 2016. Excludes 15,654 shares subject to options not exercisable within 60 days of
March 27, 2017
.
|
|
(7)
|
Includes 8,125 shares of restricted common stock subject to the Company's lapsing right of repurchase. Includes 37,172 shares subject to options exercisable within 60 days of
March 27, 2017
. Excludes 15,654 shares subject to options not exercisable within 60 days of
March 27, 2017
.
|
|
(8)
|
Includes 8,125 shares of restricted common stock subject to the Company's lapsing right of repurchase. Includes 37,172 shares subject to options exercisable within 60 days of
March 27, 2017
. Excludes 15,654 shares subject to options not exercisable within 60 days of
March 27, 2017
.
|
|
(9)
|
Includes 12,850 shares of restricted common stock subject to the Company's lapsing right of repurchase. Excludes 36,715 shares subject to options not exercisable within 60 days of
March 27, 2017
.
|
|
(10)
|
Includes 53,971 shares of restricted common stock subject to the Company's lapsing right of repurchase.
|
|
(11)
|
Includes 59,308 shares of restricted common stock subject to the Company's lapsing right of repurchase. Includes 94,623 shares subject to options exercisable within 60 days of
March 27, 2017
. Excludes 178,102 shares subject to options not exercisable within 60 days of
March 27, 2017
.
|
|
(12)
|
Includes 19,928 shares of restricted common stock subject to the Company's lapsing right of repurchase. Includes 48,866 shares subject to options exercisable within 60 days of
March 27, 2017
. Excludes 53,600 shares subject to options not exercisable within 60 days of
March 27, 2017
.
|
|
(13)
|
Includes 17,172 shares of restricted common stock subject to the Company's lapsing right of repurchase. Includes 16,115 shares subject to options exercisable within 60 days of
March 27, 2017
. Excludes 29,887 shares subject to options not exercisable within 60 days of
March 27, 2017
.
|
|
(14)
|
Includes 18,313 shares of restricted common stock subject to the Company's lapsing right of repurchase. Includes 20,710 shares subject to options exercisable within 60 days of
March 27, 2017
. Excludes 32,377 shares subject to options not exercisable within 60 days of
March 27, 2017
.
|
|
(15)
|
Includes 355,995 shares of restricted common stock subject to the Company's lapsing right of repurchase. Includes 797,123 shares subject to options exercisable within 60 days of
March 27, 2017
. Excludes 812,078 shares subject to options not exercisable within 60 days of
March 27, 2017
.
|
|
(16)
|
Information on the holdings of BlackRock, Inc. is taken from its Schedule 13G/A filed on January 17, 2017 and includes the holdings of BlackRock (Netherlands) B.V., BlackRock Advisors, LLC, BlackRock Asset Management Canada Limited, BlackRock Management Ireland Limited, BlackRock Management Schweiz AG, BlackRock Financial Management, Inc., BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., BlackRock International Limited, BlackRock Investment Management (Australia) Limited, BlackRock Investment Management (UK) Ltd., BlackRock Investment Management, LLC.
|
|
(17)
|
Information on the holdings of FMR LLC is taken from its Schedule 13G/A filed on February 14, 2017. Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the family of Abigail P. Johnson are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B stockholders have entered into a stockholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the stockholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. Neither FMR LLC nor Abigail P. Johnson has the sole power to vote or direct the voting of the shares owned directly by the various companies registered under the Investment Company Act ("
Fidelity Funds
") advised by Fidelity Management & Research Company ("
FMR Co.
"), a wholly owned subsidiary of FMR LLC, which power resides with the Fidelity Funds' Boards of Trustees. FMR Co. carries out the voting of the shares under written guidelines established by the Fidelity Funds' Boards of Trustees.
|
|
(18)
|
Information on the holdings of The Vanguard Group is taken from its Schedule 13G/A filed on February 9, 2017. Vanguard Fiduciary Trust Company, a wholly-owned subsidiary of The Vanguard Group, Inc., is the beneficial owner of 79,970 shares of our Common Stock as a result of its serving as investment manager of collective trust accounts. Vanguard Investments
|
|
Name
|
Age
|
Position
|
Class
|
Term Expiration Year
|
|
Stephen G. Waldis
|
49
|
Executive Chairman of the Board
|
Class III
|
2018
|
|
Ronald W. Hovsepian
|
56
|
Chief Executive Officer
|
Class I
|
2019
|
|
William J. Cadogan
|
68
|
Director
|
Class III
|
2018
|
|
Thomas J. Hopkins
|
60
|
Director
|
Class II
|
2017
|
|
James M. McCormick
|
57
|
Director
|
Class I
|
2019
|
|
Donnie M. Moore
|
68
|
Director
|
Class I
|
2019
|
|
Name
|
Audit Committee
|
Compensation Committee
|
Nominating/Corporate Governance Committee
|
Business Development Committee
|
|
Stephen G. Waldis
|
|
|
|
M
|
|
Ronald W. Hovsepian
|
|
|
|
|
|
William J. Cadogan
|
M
|
C
|
M
|
M
|
|
Thomas J. Hopkins
|
M*
|
M
|
|
C
|
|
James M. McCormick
|
|
M
|
C
|
|
|
Donnie M. Moore
|
C*
|
|
M
|
|
|
C
|
Chair
|
|
M
|
Member
|
|
*
|
Audit Committee Financial Expert
|
|
|
|
|
DIRECTOR NOMINEE
|
Director Since: 2004
Age: 60
Synchronoss Committees:
•
Audit
•
Compensation
•
Business Development (Chair)
|
|
Thomas J. Hopkins
is a Managing Director of Colchester Capital, LLC, an investment firm. Prior to Colchester Capital, Mr. Hopkins was involved in investment banking, principally at Deutsche Bank (and its predecessor Alex, Brown & Sons), Goldman, Sachs & Co. and Bear Stearns. He began his investment banking career at Drexel Burnham Lambert. Prior to investment banking, Mr. Hopkins was a lawyer for several years. Mr. Hopkins received a Bachelor of Arts degree from Dartmouth College, a juris doctorate from Villanova University School of Law and a master in business administration degree from the Wharton School at the University of Pennsylvania. Our Board believes Mr. Hopkins' qualifications to sit on our Board include his extensive financial expertise and his years of experience providing strategic advisory services to complex organizations.
|
Director Since: 2005
Age: 68
Synchronoss Committees:
•
Audit
•
Compensation (Chair)
•
Nominating/Corporate Governance
• Business Development
•
Nominating/Corporate
Governance
|
|
William J. Cadogan
served as a Senior Managing Director with Vesbridge Partners, LLC, formerly St. Paul Venture Capital, a venture capital firm from 2001 until 2006. Mr. Cadogan served as Chief Executive Officer and Chairman of the board of directors of Mahi Networks, Inc., a leading supplier of multi-service optical transport and switching solutions, from November 2004 until its merger with Meriton Networks in October 2005. Prior to joining St. Paul Venture Capital in 2001, Mr. Cadogan was Chairman and Chief Executive Officer of ADC, Inc., a leading global supplier of telecommunications infrastructure products and services. Mr. Cadogan received a Bachelor of Arts degree in electrical engineering from Northeastern University and a master in business administration degree from the Wharton School at the University of Pennsylvania. Our Board believes Mr. Cadogan's qualifications to sit on our Board include his experience as a CEO leading complex global organizations, combined with his operational and corporate governance expertise.
|
Founder and Former Chief Executive Officer
Executive Chairman of the Board
Director Since: 2001
Age: 49
Synchronoss Committee:
•
Business Development
|
|
Stephen G. Waldis
has served as our Executive Chairman since January 2017, having service as Chairman of the Board of Directors since 2001 Chief Executive Officer from 2000 until January 2017 and as a director since founding Synchronoss in 2000. From 2000 until 2011, Mr. Waldis also served as President. From 1994 to 2000, Mr. Waldis served as Chief Operating Officer at Vertek Corporation, a privately held professional services company serving the telecommunications industry. From 1992 to 1994, Mr. Waldis served as Vice President of Sales and Marketing of Logical Design Solutions, a provider of telecom and interactive solutions. From 1989 to 1992, Mr. Waldis worked in various technical and product management roles at AT&T. Mr. Waldis received a Bachelor of Arts degree in corporate communications from Seton Hall University. Our Board believes Mr. Waldis' qualifications to sit on our Board include his extensive experience in the software and services industry, and serving as our Chief Executive Officer and one of our founders.
|
Chief Executive Officer
Director Since: 2017
Age: 56
|
|
Ronald W. Hovsepian
has served as our Chief Executive Officer and a member of the Board since January 2017. Previously, from December 2011 until its sale to Synchronoss in January 2017, Mr. Hovsepian served as President, Chief Executive Officer and Director of Intralinks. Prior to his role at Intralinks, Mr. Hovsepian served as President and Chief Executive Officer of Novell, Inc. from 2006 until Novell’s acquisition by the Attachmate Group in April 2011. He joined Novell in 2003 as President, North America, and next served as Executive Vice President and President, worldwide field operations, and as President and Chief Operating Officer from 2005 until his appointment as Chief Executive Officer in
2006. Prior to his time at Novell, Mr. Hovsepian held a series of management and executive positions at IBM Corporation over an approximately 17-year period, including worldwide general manager of IBM’s distribution industries, manager of global hardware and software development, sales, marketing and services. Mr. Hovsepian currently serves as a member of the board of directors of ANSYS, Inc., an engineering simulation software publicly-held company, a role he has held since 2012, and, from November 2014 to December 2016, he also held the position of non-executive chairman. From 1998 to 2015, Mr. Hovsepian served as a member of the board of directors of ANN Inc., a women’s fashion retailer. He also held the position of non-executive chairman of ANN’s board of directors from 2005 to 2015. Mr. Hovsepian received a Bachelor of Science degree from the Carroll School of Management at Boston College. Our Board believes Mr. Hovsepian's qualifications to sit on our Board include his extensive experience in the software and services industry, as well as his position as our Chief Executive Officer.
|
Founder
Director Since: 2000
Age: 57
Synchronoss Committees:
•
Compensation
•
Nominating/Corporate Governance (Chair)
|
|
James M. McCormick
is a founder of Synchronoss, has been a member of our Board since our inception in 2000 and served as our Treasurer from September 2000 until December 2001. Mr. McCormick is founder and Chief Executive Officer of Vertek Corporation. Prior to founding Vertek in 1988, Mr. McCormick was a member of the Technical Staff at AT&T Bell Laboratories. Mr. McCormick received a Bachelor of Science degree in computer science from the University of Vermont and a master of science degree in computer science from the University of California — Berkeley. Our Board believes Mr. McCormick's qualifications to sit on our Board include his over 25 years in the consulting, telecommunications and services business, as well as being one of our founders.
|
Director Since: 2007
Age: 68
Synchronoss Committees:
•
Audit (Chair)
•
Nominating/Corporate Governance
|
|
Donnie M. Moore
was Senior Vice President, Finance and Administration and Chief Financial Officer for Cognos Incorporated, a publicly-held company providing business intelligence and performance management solutions, from 1989 until his retirement in 2001. From 1986 to 1989, Mr. Moore was Vice President, Finance and Chief Financial Officer of Cognos. Before joining Cognos, Mr. Moore held various positions at the Burroughs Corporation from 1973 to 1986, including Corporate Director, Plans and Analysis. Mr. Moore holds a Bachelor of Science degree in engineering from the University of Oklahoma and a master in business administration degree from the University of Houston. Our Board believes Mr. Moore's qualifications to sit on our Board include his extensive experience in the software industry and his financial expertise.
|
|
|
|
|
Fiscal Year Ended
|
||||||
|
|
|
|
2016
|
|
2015
|
||||
|
|
|
|
(In thousands)
|
||||||
|
|
Audit Fees
(1)
|
|
$
|
3,025
|
|
|
$
|
2,281
|
|
|
|
Audit Related Fees
(2)
|
|
235
|
|
|
2
|
|
||
|
|
Total Fees
|
|
$
|
3,260
|
|
|
$
|
2,283
|
|
|
(1)
|
For professional services rendered for the audits of annual financial statements, including the audit of annual financial statements and audit of internal control over financial reporting for the years ended
December 31, 2016
and
2015
. The audit fees also include the review of quarterly financial statements included in the Company's quarterly reports on Form 10-Q, statutory audits of foreign subsidiaries and other regulatory filings or similar engagements.
|
|
(2)
|
Includes fees that are for assurance and related services other than those included in Audit Fees and primarily relate to due diligence services relating to an acquisition.
|
|
RESOLVED:
|
That the stockholders approve, on an advisory non-binding basis, the compensation of the Company's named executive officers as disclosed pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis, related compensation tables, and the accompanying narrative disclosure set forth in the Proxy Statement relating to the Company's
2017
Annual Meeting of Stockholders.
|
|
RESOLVED:
|
That the stockholders approve, on a non-binding, advisory basis, the submission by the Company of a non-binding, advisory say-on-pay resolution pursuant to Section 14A of the Exchange Act every:
|
|
|
Year ended December 31,
|
||||||
|
|
2016
|
|
2015
|
||||
|
GAAP Revenue
|
$
|
476,750
|
|
|
$
|
428,117
|
|
|
Add: Deferred revenue write-down
|
13,456
|
|
|
1,260
|
|
||
|
Non-GAAP Revenue
|
$
|
490,206
|
|
|
$
|
429,377
|
|
|
|
Year ended December 31,
|
||||||
|
|
2016
|
|
2015
|
||||
|
GAAP Gross Margin
|
$
|
282,552
|
|
|
$
|
272,830
|
|
|
Add: Deferred revenue write-down
|
13,456
|
|
|
1,260
|
|
||
|
Add: Fair value stock-based compensation
|
5,669
|
|
|
5,091
|
|
||
|
Add: Acquisition and restructuring costs
|
17,482
|
|
|
8,814
|
|
||
|
Add: Deferred compensation expense - earn-out
|
—
|
|
|
—
|
|
||
|
Non-GAAP Gross Margin
|
$
|
319,159
|
|
|
$
|
287,995
|
|
|
Non-GAAP Gross Margin %
|
65
|
%
|
|
67
|
%
|
||
|
|
Year ended December 31,
|
||||||
|
|
2016
|
|
2015
|
||||
|
GAAP (loss) income from operations
|
$
|
(71,809
|
)
|
|
$
|
15,131
|
|
|
Add: Deferred revenue write-down
|
13,456
|
|
|
1,260
|
|
||
|
Add: Fair value stock-based compensation
|
32,340
|
|
|
29,867
|
|
||
|
Add: Acquisition and restructuring costs
|
52,305
|
|
|
22,479
|
|
||
|
Add: Net change in contingent consideration obligation
|
10,930
|
|
|
760
|
|
||
|
Add: Deferred compensation expense - earn-out
|
—
|
|
|
—
|
|
||
|
Add: Amortization expense
|
44,738
|
|
|
26,659
|
|
||
|
Non-GAAP income from operations
|
81,960
|
|
|
96,156
|
|
||
|
Depreciation and amortization
|
99,311
|
|
|
72,152
|
|
||
|
Less: Non-GAAP Amortization expense adjustment
|
44,738
|
|
|
26,659
|
|
||
|
Non-GAAP EBITDA
|
$
|
136,533
|
|
|
$
|
141,649
|
|
|
|
Year ended December 31,
|
||||||
|
|
2016
|
|
2015
|
||||
|
GAAP Net (loss) income from continuing operations attributable to Synchronoss
|
$
|
(54,945
|
)
|
|
$
|
363
|
|
|
Add: Deferred revenue write-down
|
13,456
|
|
|
1,260
|
|
||
|
Add: Fair value stock-based compensation
|
32,340
|
|
|
29,867
|
|
||
|
Add: Acquisition and restructuring costs
|
52,305
|
|
|
22,479
|
|
||
|
Add: Net change in contingent consideration obligation, net of Fx change
|
10,930
|
|
|
760
|
|
||
|
Add: Deferred compensation expense - earn-out
|
—
|
|
|
—
|
|
||
|
Add: Amortization expense
|
44,738
|
|
|
26,659
|
|
||
|
Less: Noncontrolling interest non-GAAP adjustments
|
(5,523
|
)
|
|
(183
|
)
|
||
|
Less: Tax effect
|
(33,583
|
)
|
|
(18,592
|
)
|
||
|
Non-GAAP Net income from continuing operations attributable to Synchronoss
|
$
|
59,718
|
|
|
$
|
62,613
|
|
|
Income effect for interest on convertible debt, net of tax
|
2,197
|
|
|
2,302
|
|
||
|
Net income from continuing operations for diluted EPS calculation
|
$
|
61,915
|
|
|
$
|
64,915
|
|
|
|
|
|
|
||||
|
Diluted non-GAAP net income per share from continuing operations
|
$
|
1.28
|
|
|
$
|
1.36
|
|
|
|
|
|
|
||||
|
Weighted shares outstanding - Diluted
|
48,518
|
|
|
47,653
|
|
||
|
|
|
December 31, 2016
|
||||||||||
|
|
|
GAAP Revenue
|
|
Deferred Revenue Write-Down
|
|
Non-GAAP Revenue
|
||||||
|
Cloud
|
|
$
|
389,925
|
|
|
$
|
13,456
|
|
|
$
|
403,381
|
|
|
Activation
|
|
86,825
|
|
|
—
|
|
|
86,825
|
|
|||
|
Total
|
|
$
|
476,750
|
|
|
$
|
13,456
|
|
|
$
|
490,206
|
|
|
|
|
December 31, 2015
|
||||||||||
|
|
|
GAAP Revenue
|
|
Deferred Revenue Write-Down
|
|
Non-GAAP Revenue
|
||||||
|
Cloud
|
|
$
|
315,832
|
|
|
$
|
1,260
|
|
|
$
|
317,092
|
|
|
Activation
|
|
112,285
|
|
|
—
|
|
|
112,285
|
|
|||
|
Total
|
|
$
|
428,117
|
|
|
$
|
1,260
|
|
|
$
|
429,377
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|